Prof. AHMET OĞUZHAN ÖZEN

Articles

2026

1. The Experience of a Tertiary Reference Center in Central Anatolia with Children Carrying ZAP-70 Variants, Including Two Novel Variants

GÖKTAŞ S., Kalaycik Sengul O., Erdem Ş., Eke Güngör H., Babayeva R., BİLGİÇ ELTAN S., et al.

Journal of Clinical Immunology , vol.46, no.1, 2026 (SCI-Expanded, Scopus)

2026

2. Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity

YORĞUN ALTUNBAŞ M., Sefer A. P., BİLGİÇ ELTAN S., Yildirimcakar C., Ozturk P., Dikici Ü., et al.

Journal of Clinical Immunology , vol.46, no.1, 2026 (SCI-Expanded, Scopus)

2026

3. The MENAT Region Inborn Errors of Immunity Research Consortium Registry (MENAT-IEI-RCR): Establishing a regional framework for collaborative research

Barbouche M., Al-Herz W., Karim M. Y., Lo B., ÖZEN A. O., Rezaei N., et al.

Clinical Immunology , vol.284, 2026 (SCI-Expanded, Scopus)

2026

4. Lessons learnt from the COVID-19 pandemic: Middle East and North Africa regional perspective for future preparedness

Farag N. H., ÖZEN A. O., Spaulding A. B., Khan G., Barbouche M. R., Khan M. A., et al.

BMJ Global Health , vol.11, no.3, 2026 (SCI-Expanded, SSCI, Scopus)

2026

5. SPINK5 Variants Drive Clinical Variability in Netherton Syndrome Through Th2/Th17 Skewing and Influence Therapeutic Outcomes.

Yorgun Altunbas M., Topal E., Bayram-Catak F., Catak M. C., Amirov R., Colak B. C., et al.

The journal of allergy and clinical immunology. In practice , 2026 (SCI-Expanded, Scopus)

2026

6. Evaluating pozelimab in the treatment of CHAPLE disease

Ozturk N. K., Demirkaya D. B., Bulutoglu A., Sefer A. P., ÖZEN A. O.

Immunotherapy , 2026 (SCI-Expanded, Scopus)

2026

7. Activated PI3Kδ syndrome in inborn errors of immunity: diagnostic strategies and clinical challenges

Bozkurt S., Ozturk N., Altunbas M. Y., CAN S., Amirov R., Mahmudov R., et al.

Frontiers in Immunology , vol.16, 2026 (SCI-Expanded, Scopus)

2025

8. The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition

Litcher-Kelly L., ÖZEN A. O., Ollis S., Feldman H. B., Yaworsky A., Medrano P., et al.

Orphanet Journal of Rare Diseases , vol.20, no.1, 2025 (SCI-Expanded)

2025

9. Abatacept restores dysregulated transcriptomic and proteomic profile in disorders of CTLA-4 insufficiency

Catak M. C., Surucu N., Bayram Catak F., Kara A., Cildir S., Babayeva R., et al.

Journal of Allergy and Clinical Immunology , vol.156, no.6, pp.1725-1742, 2025 (SCI-Expanded, Scopus)

2025

10. Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey

Bekis Bozkurt H., Bayram Catak F., Sahin A., Yalcin Gungoren E., Gemici Karaarslan B., Yakici N., et al.

Journal of Clinical Immunology , vol.45, no.1, 2025 (SCI-Expanded, Scopus)

2025

11. The Discrepancy Between Perceived and Proven Drug Hypersensitivity in a Well-Defined Cohort of Patients With Inborn Errors of Immunity.

Bilgic-Eltan S., Karakurt T., Yuksel R. G., Yalaki A. I., Durankus F., Dut R., et al.

Allergy , vol.80, no.11, pp.3140-3150, 2025 (SCI-Expanded, Scopus)

2025

12. Clinical, Immunological Prognostic Factors and Novel Variants in Large Cohort of DGAT1 Deficiency.

Yorgun Altunbas M., Kogler H., Abolhassani H., Akkus E., Basturk A., Akkelle E., et al.

The journal of allergy and clinical immunology. In practice , vol.13, no.9, pp.2449, 2025 (SCI-Expanded)

2025

13. The impact of genetic immune disorders on infections including COVID-19, inflammatory bowel disease and cancer

Xiang C., Park A. Y., Weber S. E., Lenardo M. J., ÖZEN A. O., Cui J.

Nature Immunology , vol.26, no.9, pp.1440-1452, 2025 (SCI-Expanded, Scopus)

2025

14. Comprehensive αβ T-Cell Receptor Repertoire Analysis Reveals a Unique CD8+ TCR Landscape in DOCK8-Deficient Patients.

Bozkurt C., Cildir G., Aba U., Erdogan R. K., Warnock N. I., Kok C. H., et al.

Allergy , vol.80, no.9, pp.2519-2530, 2025 (SCI-Expanded)

2025

15. Complement Dysregulation at Lymphatics.

Ozen A. O., Can S., Sefer A. P., Ozturk N. K., Colak B. C.

The Journal of allergy and clinical immunology , vol.156, pp.205-214, 2025 (SCI-Expanded)

2025

16. Listeria Meningitis as an Indication of Undiagnosed Primary Immune Deficiency, Activated Phosphoinositide 3-Kinase Delta Syndrome: A Case Report.

Erdemli P. C., Demir S., Bozkurt S., Tuncay S. A., Yılmaz S., Parlak B., et al.

The Pediatric infectious disease journal , vol.44, no.7, pp.672-675, 2025 (SCI-Expanded)

2025

17. Invasive Mould Infections in Chronic Granulomatous Disease: A Multicenter Study From Türkiye

Ergenc Z., Eltan S. B., Karaaslan B. G., Kiykim A., Tuncay S. A., Yilmaz S., et al.

Mycoses , vol.68, no.7, 2025 (SCI-Expanded, Scopus)

2025

18. Subjective assessment of sleep quality in adult patients with hereditary angioedema.

Karabiber E., Güngören E. Y., Özen A. O., Barış S., Karakoc-Aydiner E.

Frontiers in neurology , vol.16, pp.1555562, 2025 (SCI-Expanded, Scopus)

2025

19. Cross-sectional Analysis of Health Quality, Treatment Satisfaction and Adherence in Children with Food Allergy

Günal Ö., Sefer A. P., Ütük B., Altunbas M. Y., Güngören E. Y., Babayeva R., et al.

Clinical and Experimental Health Sciences , vol.15, no.1, pp.217-225, 2025 (ESCI)

2025

20. Microbial Isolates and Antimicrobial Resistance Patterns in Adults with Inborn Errors of Immunity: A Retrospective Longitudinal Analysis of Sputum Cultures

Karabiber E., İLKİ Z. A., GÖKDEMİR Y., VATANSEVER H. M., Olgun Ylldlzeli Ş., ÖZEN A. O.

International Archives of Allergy and Immunology , vol.186, no.4, pp.387-398, 2025 (SCI-Expanded, Scopus)

2025

21. Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease

Catak F. B., Catak M. C., Babayeva R., Toubia J., Warnock N. I., Celmeli F., et al.

Journal of Allergy and Clinical Immunology , vol.155, no.3, pp.784-791, 2025 (SCI-Expanded, Scopus)

2025

22. Early markers of baked milk and egg tolerance in young children with IgE-mediated immediate reactions.

Altunbas M. Y., Gungoren E. Y., Can S., Amirov R., Ozturk N., Bozkurt S., et al.

European annals of allergy and clinical immunology , 2025 (ESCI, Scopus)

2025

23. A plain language summary of a study looking at the effects of pozelimab in children with CHAPLE disease

ÖZEN A. O., Chongsrisawat V., Sefer A. P., Kolukisa B., Jalbert J. J., Meagher K. A., et al.

Future Rare Diseases , vol.5, no.1, 2025 (Scopus)

2025

24. Beyond Dermatological Findings: Multisystem Involvement in Prolidase Deficiency

Yalcin Gungoren E., Meric Z., Pinar Sefer A., Ozkan A. D., CAN S., Babayeva R., et al.

Turkish Archives of Pediatrics , vol.60, no.1, pp.48-56, 2025 (ESCI, Scopus, TRDizin)

2025

25. Clinical and molecular findings in actin-related inborn errors of immunity: the middle East and North Africa registry

Chavoshzadeh Z., Fallah S., Zeinali V., Sharafian S., Delavari S., Mesdaghi M., et al.

Frontiers in Genetics , vol.16, 2025 (SCI-Expanded, Scopus)

2025

26. Beyond the skin: immunological profiles and infectious complications in ALOX12B-associated autosomal recessive congenital ichthyosis

Sefer A. P., Catak M. C., An I., Keser Ozturk N., BAYKAL SELÇUK L., Dincer O. S., et al.

Frontiers in Immunology , vol.16, 2025 (SCI-Expanded, Scopus)

2025

27. Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

Bosticardo M., Dobbs K., Delmonte O. M., Martins A. J., Pala F., Kawai T., et al.

Science Immunology , vol.10, no.103, 2025 (SCI-Expanded, Scopus)

2025

28. An evaluation of pozelimab for the treatment of CHAPLE disease

Can S., YORĞUN ALTUNBAŞ M., ÖZEN A. O.

Expert Opinion on Biological Therapy , vol.25, no.1, pp.1-7, 2025 (SCI-Expanded)

2024

29. Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments

Litcher-Kelly L., ÖZEN A. O., Ollis S., Feldman H. B., Yaworsky A., Medrano P., et al.

Orphanet Journal of Rare Diseases , vol.19, no.1, 2024 (SCI-Expanded)

2024

30. Long-term immunological changes after corrective cardiac surgery

Bilgic-Eltan S., Amirov R., Babayeva R., Yorgun Altunbas M., Karakurt T., Can S., et al.

Scandinavian Journal of Immunology , vol.100, no.6, 2024 (SCI-Expanded, Scopus)

2024

31. DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans

Azizoglu Z. B., Babayeva R., HASKOLOĞLU Z. Ş., Acar M. B., Ayaz-Guner S., Okus F. Z., et al.

Journal of Clinical Immunology , vol.44, no.8, 2024 (SCI-Expanded, Scopus)

2024

32. Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort

Yalcin Gungoren E., YORĞUN ALTUNBAŞ M., Dikici U., Meric Z., ESER ŞİMŞEK I., KIYKIM A., et al.

Journal of Clinical Immunology , vol.44, no.8, 2024 (SCI-Expanded, Scopus)

2024

33. TREX tetramer disruption alters RNA processing necessary for corticogenesis in THOC6 Intellectual Disability Syndrome

Werren E. A., LaForce G. R., Srivastava A., Perillo D. R., Li S., Johnson K., et al.

Nature Communications , vol.15, no.1, 2024 (SCI-Expanded, Scopus)

2024

34. LTβR deficiency causes lymph node aplasia and impaired B cell differentiation

Ransmayr B., Bal S. K., Thian M., Svaton M., van de Wetering C., Hafemeister C., et al.

Science Immunology , vol.9, no.101, 2024 (SCI-Expanded, Scopus)

2024

35. MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort

Gulec Koksal Z., BİLGİÇ ELTAN S., Topyildiz E., Sezer A., Keles S., Celebi Celik F., et al.

Journal of Allergy and Clinical Immunology: In Practice , vol.12, no.9, pp.2490, 2024 (SCI-Expanded, Scopus)

2024

36. Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.

ERMAN B., Aba U., Ipsir C., Pehlivan D., Aytekin C., Cildir G., et al.

Journal of clinical immunology , vol.44, no.7, pp.157, 2024 (SCI-Expanded, Scopus)

2024

37. Neurocognitive Impairment in Patients With Ataxia Telangiectasia and Their Unaffected Parents: Is It Similar?

UYAR E., Akturk H., Usanmaz S., KIYKIM A., Tufan A. E., Alibas H., et al.

Pediatric Neurology , vol.156, pp.85-90, 2024 (SCI-Expanded)

2024

38. Antibody responses to inactivated and/or mRNA SARS-CoV-2 vaccination in patients with inborn errors of immunity

Karabiber E., Atik O., Ergan B., Tepetam F., Ilki A., ÖZEN A. O., et al.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.15, no.6, pp.388-393, 2024 (ESCI)

2024

39. Artemis deficiency: A large cohort including a novel variant with increased radiosensitivity

Meric Z., Gemici Karaaslan B., Yalcin Gungoren E., Bektas Hortoglu M., Cavas T., Aydemir S., et al.

Pediatric Allergy and Immunology , vol.35, no.6, 2024 (SCI-Expanded, Scopus)

2024

40. Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.

Karakus I. S., Catak M. C., Frohne A., Bayram Catak F., Yorgun Altunbas M., Babayeva R., et al.

Journal of clinical immunology , vol.44, no.4, pp.94, 2024 (SCI-Expanded)

2024

41. Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

ÖZEN A. O., Chongsrisawat V., Sefer A. P., KOLUKISA B., Jalbert J. J., Meagher K. A., et al.

The Lancet , vol.403, no.10427, pp.645-656, 2024 (SCI-Expanded, Scopus)

2024

42. GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway

Park A. Y., Leney-Greene M., Lynberg M., Gabrielski J. Q., Xu X., Schwarz B., et al.

Nature Immunology , vol.25, no.2, pp.282-293, 2024 (SCI-Expanded, Scopus)

2024

43. Health Quality and Treatment Satisfaction in IEI Patients; Not Only IgRT but Comorbidities

Yorğun Altunbaş M., Yalcin Gungoren E., Sefer A. P., Babayeva R., Can S., Bilgiç Eltan S., et al.

Asthma Allergy Immunology , vol.22, no.3, pp.285-308, 2024 (ESCI, Scopus, TRDizin)

2024

44. Immunologists’ Perspectives on Monogenic Inflammatory Bowel Diseases

Osman M. J. A., Aydoğdu E. S., Mackeh R., ÖZEN A. O., Lo B.

Turkish Journal of Immunology , vol.12, pp.17-36, 2024 (ESCI, Scopus, TRDizin)

2024

45. Pharmacotherapy for CD55 deficiency with CHAPLE disease: how close are we to a cure?

CAN S., YORĞUN ALTUNBAŞ M., ÖZEN A. O.

Expert Opinion on Pharmacotherapy , vol.25, no.11, pp.1421-1426, 2024 (SCI-Expanded)

2024

46. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome

Bilgic Eltan S., Nain E., Catak M. C., Ezen E., Sefer A. P., Karimi N., et al.

Journal of Clinical Immunology , vol.44, no.1, 2024 (SCI-Expanded, Scopus)

2023

47. Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.

Taghizade N., Babayeva R., Kara A., Karakus I. S., Catak M. C., Bulutoglu A., et al.

The Journal of allergy and clinical immunology , vol.152, pp.1634-1645, 2023 (SCI-Expanded, Scopus)

2023

48. Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards.

Uhlig H. H., Booth C., Cho J., Dubinsky M., Griffiths A. M., Grimbacher B., et al.

Nature reviews. Gastroenterology & hepatology , vol.20, pp.810-828, 2023 (SCI-Expanded)

2023

49. Protein-Losing Enteropathy. Reply

ÖZEN A. O., Lenardo M. J.

The New England journal of medicine , vol.389, no.19, pp.1826, 2023 (SCI-Expanded, Scopus)

2023

50. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis

Kasap N., Kara A., Celik V., Bilgic Eltan S., Akay Haci I., KÖSE H., et al.

Journal of Clinical Immunology , vol.43, no.8, pp.1882-1890, 2023 (SCI-Expanded, Scopus)

2023

51. Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome.

Labrosse R., Chu J., Armant M., Everett J. K., Pellin D., Kareddy N., et al.

Blood , vol.142, pp.1281-1296, 2023 (SCI-Expanded, Scopus)

2023

52. Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients.

Yakici N., Kreins A. Y., Catak M. C., Babayeva R., Erman B., Kenney H., et al.

Clinical immunology (Orlando, Fla.) , vol.255, pp.109757, 2023 (SCI-Expanded, Scopus)

2023

53. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.

Maccari M. E., Wolkewitz M., Schwab C., Lorenzini T., Leiding J. W., Aladjdi N., et al.

The Journal of allergy and clinical immunology , vol.152, 2023 (SCI-Expanded, Scopus)

2023

54. Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.

Karabiber E., Atik Ö., Tepetam F. M., Ergan B., İlki A., Karakoç Aydıner E., et al.

Tuberkuloz ve toraks , vol.71, no.3, pp.236-249, 2023 (ESCI, Scopus, TRDizin)

2023

55. Biallelic NFATC1 mutations cause an inborn error of immunity with impaired CD8+ T-cell function and perturbed glycolysis

Kostel Bal S., Giuliani S., Block J., Repiscak P., Hafemeister C., Shahin T., et al.

Blood , vol.142, no.9, pp.827-845, 2023 (SCI-Expanded, Scopus)

2023

56. Protein-Losing Enteropathy.

Ozen A. O., Lenardo M. J.

The New England journal of medicine , vol.389, no.8, pp.733-748, 2023 (SCI-Expanded)

2023

57. Defective Treg generation and increased type 3 immune response in leukocyte adhesion deficiency 1

Erdem S., Haskologlu S., Haliloglu Y., Celikzencir H., Arik E., Keskin O., et al.

Clinical Immunology , vol.253, 2023 (SCI-Expanded, Scopus)

2023

58. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6

BARIŞ S., Benamar M., Chen Q., Catak M. C., Martínez-Blanco M., Wang M., et al.

Journal of Allergy and Clinical Immunology , vol.152, no.1, pp.182, 2023 (SCI-Expanded, Scopus)

2023

59. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.

Leiding J. W., Vogel T. P., Santarlas V. G. J., Mhaskar R., Smith M. R., Carisey A., et al.

The Journal of allergy and clinical immunology , vol.151, pp.1081-1095, 2023 (SCI-Expanded, Scopus)

2023

60. The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children

Benamar M., Chen Q., Chou J., Julé A. M., Boudra R., Contini P., et al.

JOURNAL OF CLINICAL INVESTIGATION , vol.133, no.1, 2023 (SCI-Expanded, Scopus)

2023

61. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity

Baris S., Abolhassani H., Massaad M. J., Al-Nesf M., Chavoshzadeh Z., Keles S., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.11, no.1, 2023 (SCI-Expanded, Scopus)

2022

62. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

Lévy R., Gothe F., Momenilandi M., Magg T., Materna M., Peters P., et al.

JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2, 2022 (SCI-Expanded, Scopus)

2022

63. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry

Jamee M., Azizi G., BARIŞ S., Karakoc-Aydiner E., ÖZEN A. O., KILIÇ GÜLTEKİN S. Ş., et al.

CLINICAL IMMUNOLOGY , vol.244, 2022 (SCI-Expanded, Scopus)

2022

64. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency

Catak M. C., Akcam B., Bilgic Eltan S., Babayeva R., Karakus I. S., Akgun G., et al.

ALLERGY , vol.77, no.10, pp.3108-3123, 2022 (SCI-Expanded, Scopus)

2022

65. Increased radiosensitivity and impaired DNA repair in patients with STAT3-LOF and ZNF341 deficiency, potentially contributing to malignant transformations

Cekic S., Huriyet H., Hortoglu M., Kasap N., Ozen A. O., Karakoc-Aydiner E., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.209, no.1, pp.83-89, 2022 (SCI-Expanded, Scopus)

2022

66. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency

Ozturk E., Catak M. C., Kiykim A., Baser D., Bilgic Eltan S., Yalcin K., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.42, no.5, pp.1036-1050, 2022 (SCI-Expanded, Scopus)

2022

67. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency

Sefer A. P., Abolhassani H., Ober F., KAYAOĞLU B., Eltan S. B., Kara A., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.42, no.3, pp.634-652, 2022 (SCI-Expanded, Scopus)

2022

68. Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency

Yilmaz N. S., Eltan S. B., KAYAOĞLU B., Geckin B., Heredia R. J., Sefer A. P., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.42, pp.582-596, 2022 (SCI-Expanded, Scopus)

2022

69. Mucus sialylation determines intestinal host-commensal homeostasis.

Yao Y., Kim G., Shafer S., Chen Z., Kubo S., Ji Y., et al.

Cell , vol.185, no.7, 2022 (SCI-Expanded, Scopus)

2022

70. Management of Inborn Errors of Immunity in the Genomic Era

Demir D. D., Asnaashari K., Rezaei N., Ozen A.

TURKISH ARCHIVES OF PEDIATRICS , vol.57, no.2, pp.132-145, 2022 (ESCI)

2022

71. A boy with a novel homozygous ZAP70 mutation presenting with a dermatological phenotype and postnatal decrease in CD8(+) T cells

Babayeva R., Mongellaz C., Karakus I. S., Cansever M., Bilgic Eltan S., Catak M. C., et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.33, no.3, 2022 (SCI-Expanded)

2022

72. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls

Senturk G., Ng Y. Y., Eltan S. B., Baser D., Ogulur I., Altindirek D., et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY , vol.95, 2022 (SCI-Expanded, Scopus)

2022

73. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency

Kolukisa B., Baser D., Akcam B., Danielson J., Bilgic Eltan S., Haliloglu Y., et al.

ALLERGY , vol.77, no.3, pp.1004-1019, 2022 (SCI-Expanded, Scopus)

2022

74. Primary antibody deficiencies in Turkey: molecular and clinical aspects

Firtina S., Ng Y. Y., HATIRNAZ NG Ö., Kiykim A., Ozek E. Y., Kara M., et al.

IMMUNOLOGIC RESEARCH , vol.70, no.1, pp.44-55, 2022 (SCI-Expanded)

2022

75. Therapeutic options for CTLA-4 insufficiency.

Egg D., Rump I. C., Mitsuiki N., Rojas-Restrepo J., Maccari M., Schwab C., et al.

The Journal of allergy and clinical immunology , vol.149, pp.736-746, 2022 (SCI-Expanded)

2022

76. The Attitudes of Patients' Parents Receiving Allergen-Specific Immunotherapy Against Anaphylaxis

BERBER M., ERCAN SARIÇOBAN H., Ugras M., Ozen A.

ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2, pp.71-76, 2022 (ESCI)

2022

77. Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease

Kubo S., Fritz J. M., Raquer-McKay H. M., Kataria R., Vujkovic-Cvijin I., Al-Shaibi A., et al.

NATURE IMMUNOLOGY , vol.23, no.1, pp.75-101, 2022 (SCI-Expanded, Scopus)

2022

78. Adverse COVID-19 outcomes in immune deficiencies: Inequality exists between subclasses.

AYDINER E., Eltan S., Babayeva R., Aydiner O., KEPENEKLİ KADAYİFCİ E., KOCAMIŞ B., et al.

Allergy , vol.77, no.1, pp.282-295, 2022 (SCI-Expanded, Scopus)

2021

79. COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly.

Rzymski P., Camargo C. A., Fal A., Flisiak R., Gwenzi W., Kelishadi R., et al.

Vaccines , vol.9, no.11, 2021 (SCI-Expanded)

2021

80. Impaired respiratory burst contributes to infections in PKC-deficient patients

Neehus A., Moriya K., Nieto-Patlán A., Le Voyer T., Lévy R., Özen A. O., et al.

JOURNAL OF EXPERIMENTAL MEDICINE , vol.218, no.9, 2021 (SCI-Expanded, Scopus)

2021

81. Adverse COVID outcomes in youngsters with immune deficiencies; inequality exists between subclasses

AYDINER E., Eltan S. B., Babayeva R., Aydiner O., KEPENEKLİ KADAYİFCİ E., KOLUKISA B., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.285, 2021 (SCI-Expanded)

2021

82. Genomic investigation into early onset protein-losing enteropathies: therapeutic implications and insights into clusters of shared pathomechanisms

Sefer A. P., AYDINER E., Urganci N., Kiykim E., Baysoy G., Fisher M., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.371, 2021 (SCI-Expanded)

2021

83. Inflammatory Bowel Disease and Guillain Barre Syndrome in FCHO1 Deficiency

Aydemir S., Islek A., Nepesov S., Yaman Y., Baysoy G., Beser O. F., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.6, pp.1406-1410, 2021 (SCI-Expanded, Scopus)

2021

84. Autoinflammatory manifestations as a result of an elevated type I IFN signature in a case of NEMO deficiency

Yilmaz N. S., Eltan S. B., KAYAOĞLU B., Geckin B., Sozeri B., KIYKIM A., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.370, 2021 (SCI-Expanded)

2021

85. Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor Deficiency

ÇAĞDAŞ AYVAZ D. N., Mayr D., BARIŞ S., Worley L., Langley D. B., Metin A., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.6, pp.1272-1290, 2021 (SCI-Expanded, Scopus)

2021

86. CHAPLE disease and non-CHAPLE protein losing enteropathies: natural history and immune characteristics

Selcuk M., Sefer A. P., Baser D., Ogulur I., Eltan S. B., Dursun E., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.83, 2021 (SCI-Expanded, Scopus)

2021

87. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity

Aghamohammadi A., Rezaei N., Yazdani R., Delavari S., KÜTÜKÇÜLER N., Topyildiz E., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, pp.1339-1351, 2021 (SCI-Expanded, Scopus)

2021

88. Reversal clinical and immunological effects of abatacept in patients with LRBA and CTLA4 deficiencies

BARIŞ S., Babayeva R., Catak M. C., Baser D., Eltan S. B., Akgun G., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.77, 2021 (SCI-Expanded)

2021

89. The epithelial barrier damaging effects of professional dishwasher rinse aid on Caco-2 gastrointestinal epithelial cells

Ogulur I., Ruckert B., Ozen A. O., Akdis C. A.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.184, 2021 (SCI-Expanded)

2021

90. Single cell sequencing of peripheral mononuclear cells reveals CHAPLE-specific distinct signaling pathways

Ogulur I., Kim J., Ruckert B., Pat Y., AYDINER E., BARIŞ S., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.372, 2021 (SCI-Expanded)

2021

91. Reference values for T and B lymphocyte subpopulations in Turkish children and adults.

Besci Ö., Başer D., Öğülür İ., Berberoğlu A. C., Kıykım A., Besci T., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.30, no.51 (4), pp.1814-1824, 2021 (SCI-Expanded)

2021

92. Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency

Shafer S., Yao Y., Comrie W., Cook S., Zhang Y., Yesil G., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , vol.148, no.1, pp.256-263, 2021 (SCI-Expanded, Scopus)

2021

93. GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension

Drzewiecki K., Choi J., Brancale J., Leney-Greene M. A., Sari S., Dalgiç B., et al.

JOURNAL OF EXPERIMENTAL MEDICINE , vol.218, no.7, 2021 (SCI-Expanded, Scopus)

2021

94. Lymphopenia with Low T and NK Cells in a Patient with USB1 Mutation, Rare Findings in Clericuzio-Type Poikiloderma with Neutropenia

Bilgic Eltan S., Sefer A. P., Karakus İ. S., ÖZEN A. O., Karakoc-Aydiner E., BARIŞ S.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.5, pp.1106-1111, 2021 (SCI-Expanded, Scopus)

2021

95. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation

Kayaoglu B., Kasap N., Yilmaz N. S., Charbonnier L. M., Geckin B., Akcay A., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.4, pp.769-779, 2021 (SCI-Expanded, Scopus)

2021

96. Heterozygous AIRE Mutation in a Family with Multiple Autoimmune Organ Involvement

Sefer A. P., Kolukisa B. K., Akcam B., Demirkol Y. K., Aydiner E., Ozen A., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.SUPPL 1, 2021 (SCI-Expanded)

2021

97. CARMIL2 Deficiency And Various Clinical Phenotypes: Warning Signs For Early Diagnosis

Kolukisa B. K., Kasap N., Eltan S. B., Baser D., Akgun G., Sefer A. P., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, 2021 (SCI-Expanded)

2021

98. The evaluation of radiosensitivity in patients with STAT3 deficiency

ÇEKİÇ Ş., Huriyet H., BEKTAŞ HORTOĞLU M., Baris S., Metin A., Ozen A. O., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, 2021 (SCI-Expanded)

2021

99. Homozygous IL37 mutation associated with infantile inflammatory bowel disease

Zhang Z. Z., Zhang Y., He T., Sweeney C. L., Baris S., Karakoc-Aydiner E., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , vol.118, no.10, 2021 (SCI-Expanded, Scopus)

2021

100. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis

Kasap N., Celik V., Isik S., Cennetoglu P., Kiykim A., Eltan S. B., et al.

CLINICAL IMMUNOLOGY , vol.223, 2021 (SCI-Expanded, Scopus)

2021

101. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

Meyts I., Bucciol G., Quinti I., Neven B., Fischer A., Seoane E., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , vol.147, no.2, pp.520-531, 2021 (SCI-Expanded, Scopus)

2021

102. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease

Ozen A. O., Kasap N., Vujkovic-Cvijin I., Apps R., Cheung F., Karakoc-Aydiner E., et al.

NATURE IMMUNOLOGY , vol.22, no.2, pp.128-151, 2021 (SCI-Expanded, Scopus)

2021

103. Parents of ataxia-telangiectasia patients display a distinct cellular immune phenotype mimickingATM-mutated patients

ÖĞÜLÜR İ., Ertuzun T., KOCAMIŞ B., Kendir Demirkol Y., UYAR E., KIYKIM A., et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.32, no.2, pp.349-357, 2021 (SCI-Expanded, Scopus)

2021

104. Novel Frameshift Autosomal Recessive Loss-of-Function Mutation inSMARCD2Encoding a Chromatin Remodeling Factor Mediates Granulopoiesis

Yucel E., Karakus I. S., Krolo A., KIYKIM A., Heredia R. J., Tamay Z., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.1, pp.59-65, 2021 (SCI-Expanded, Scopus)

2021

105. Prevalence of allergic disorders and risk factors associated with food allergy in Turkish preschoolers

Aksoy A. G., BORAN P., Karakoc-Aydiner E., Gokcay G., TAMAY Z. Ü., Devecioglu E., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.49, no.1, pp.11-16, 2021 (SCI-Expanded, Scopus)

2021

106. Primary immun deficiency in patients with non-cystic fibrosis bronchiectasis and its relationship with clinical parameters

BEKIR KULAH M., AYDINER E., OLGUN YILDIZELİ Ş., ÖĞÜLÜR İ., KOCAKAYA D., BARIŞ S., et al.

Turkish Thoracic Journal , vol.22, no.1, pp.37-44, 2021 (ESCI, Scopus, TRDizin)

2021

107. A Patient with Novel ICOS Mutation Presented with Progressive Loss of B Cells

Sefer A. P., Charbonnier L. M., Kasap N., Akcam B., Demirkol Y. K., Eltan S. B., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.1, pp.251-255, 2021 (SCI-Expanded)

2021

108. Reference values for T and B lymphocyte subpopulations in Turkish children and adults

Bescİ Ö., BaŞer D., ÖĞÜlÜr İ., BerberoĞlu A. C., Kiykim A., Bescİ T., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1814-1824, 2021 (SCI-Expanded, Scopus, TRDizin)

2020

109. Mutational landscape of severe combined immunodeficiency patients from Turkey

Firtina S., Ng Y. Y., Ng O. H., Kiykim A., AYDINER E., Nepesov S., et al.

INTERNATIONAL JOURNAL OF IMMUNOGENETICS , vol.47, no.6, pp.529-538, 2020 (SCI-Expanded, Scopus)

2020

110. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency

Ghosh S., Köstel B., Edwards E., Pillay B., Jiménez H., Erol C., et al.

BLOOD , vol.136, no.23, pp.2638-2655, 2020 (SCI-Expanded, Scopus)

2020

111. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort

Baris H. E., Ogulur I., Akcam B., Kiykim A., Karagoz D., Saraymen B., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.8, no.10, pp.3525-3535, 2020 (SCI-Expanded, Scopus)

2020

112. Hematopoietic stem cell transplantation in CD40 ligand deficiency: A single-center experience

KOCACIK UYGUN D. F., Uygun V., Karasu G. T., Daloglu H., Ozturkmen S. I., Celmeli F., et al.

PEDIATRIC TRANSPLANTATION , vol.24, no.6, 2020 (SCI-Expanded)

2020

113. Immunization practices in children with a history of allergies

Baris H. E., BORAN P., Kiykim A., BARIŞ S., Ozen A., AYDINER E.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , vol.55, no.3, pp.244-250, 2020 (ESCI, Scopus, TRDizin)

2020

114. The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study

Cekic S., Metin A., Aytekin C., Edeer Karaca N., Baris S., Karali Y., et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.31, no.5, pp.528-536, 2020 (SCI-Expanded, Scopus)

2020

115. Management of Systemic Hypersensitivity Reactions to Gonadotropin-Releasing Hormone Analogues during Treatment of Central Precocious Puberty

Kirkgoz T., Karakoc-Aydiner E., Bugrul F., Yavas Abali Z., Helvacioglu D., Kiykim A., et al.

HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.1, pp.66-72, 2020 (SCI-Expanded, Scopus)

2020

116. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients

Eken A., Cansever M., Okus F. Z., Erdem S., Nain E., Azizoglu Z. B., et al.

Allergy: European Journal of Allergy and Clinical Immunology , vol.75, no.4, pp.921-932, 2020 (SCI-Expanded)

2020

117. Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat

Kiykim A., Eker N., Surekli O., Nain E., Kasap N., Aktürk H., et al.

Pediatric Blood and Cancer , vol.67, no.2, 2020 (SCI-Expanded, Scopus)

2020

118. Lymphocyte Subset Abnormalities in Pediatric-Onset Common Variable Immunodeficiency.

Ogulur I., Kiykim A., Baser D., Karakoc-Aydiner E., Ozen A. O., Baris S.

International archives of allergy and immunology , vol.181, no.3, pp.228-237, 2020 (SCI-Expanded)

2020

119. Autosomal recessive agammaglobulinemic patient with a novel large deletion in IGHM presenting with mild clinical phenotype

Nain E., ÜLGEN Ö., Kiykim A., Aydiner E., Ozen A. O., BARIŞ S.

CLINICAL IMMUNOLOGY , vol.210, 2020 (SCI-Expanded, Scopus)

2020

120. U100: An innovative usern platform for education and research without borders

Momtazmanesh S., Rahmani F., Delavari F., Vahedi Z., Ebadirad S., Keshavarz-Fathi M., et al.

Acta Medica Iranica , vol.58, no.1, pp.1-3, 2020 (Scopus)

2020

121. Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: A single center experience

Nain E., Kıykım A., Kasap N. A., BARIŞ S., Özen A. O., Aydıner E. K.

Turkish Journal of Pediatrics , vol.62, no.3, pp.379-386, 2020 (SCI-Expanded, Scopus, TRDizin)

2019

122. Immune system defects in DiGeorge syndrome and association with clinical course.

Nain E., Kiykim A., ÖĞÜLÜR İ., Kasap N., Karakoc-Aydiner E., Ozen A. O., et al.

Scandinavian journal of immunology , vol.90, no.5, 2019 (SCI-Expanded)

2019

123. Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress.

Conde C. D., Petronczki Ö. Y., Baris S., Willmann K. L., Girardi E., Salzer E., et al.

The Journal of clinical investigation , vol.129, no.10, pp.4194-4206, 2019 (SCI-Expanded, Scopus)

2019

124. Functional reprogramming of regulatory T cells in the absence of Foxp3

Charbonnier L., Cui Y., Stephen-Victor E., Harb H., Lopez D., Bleesing J. J., et al.

NATURE IMMUNOLOGY , vol.20, no.9, pp.1208-1226, 2019 (SCI-Expanded)

2019

125. How to Approach Systemic Hypersensitivity reactions to Gonadotropin Releasing Hormone Analogues during treatment of Central Precocious Puberty

KIRKGÖZ T., Karakoc E., Kiykim A., Bugrul F., Helvacioglu D., Eltan S. B., et al.

HORMONE RESEARCH IN PAEDIATRICS , vol.91, pp.185, 2019 (SCI-Expanded)

2019

126. A Novel FOXN1 Variant Is Identified in Two Siblings with Nude Severe Combined Immunodeficiency

Firtina S., Cipe F., Ng Y. Y., KIYKIM A., Ng O. H., Sudutan T., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.2, pp.144-147, 2019 (SCI-Expanded, Scopus)

2019

127. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

Farmer J. R., Foldvari Z., Ujhazi B., De Ravin S. S., Chen K., Bleesing J. J., et al.

The journal of allergy and clinical immunology. In practice , vol.7, no.6, 2019 (SCI-Expanded, Scopus)

2019

128. Kronik Granülomatöz Hastalarında ve Bu Hastalığı GenetikOlarak Taşıyan Bireylerde Lenfosit Fonksiyonları

BARIŞ S., KIYKIM A., ÖZEN A. O., AYDINER E., ÖĞÜLÜR İ., Akgün G., et al.

Türk İmmünoloji Dergisi , 2019 (Scopus)

2019

129. Lymphocyte Functions in Patients with Chronic Granulomatous Disease and Carrier Individuals

ÖĞÜLÜR İ., Barış E., KIYKIM A., Başer D., Akgün G., ÖZEN A. O., et al.

TURKISH JOURNAL OF IMMUNOLOGY , vol.7, no.2, pp.93-101, 2019 (ESCI)

2019

130. The Diagnostic Value of Flow Cytometry in DOCK8 Deficiency

ÖĞÜLÜR İ., Kiykim A., Nain E., Kasap N., Akgün G., Karakoç-Aydiner E., et al.

TURKISH JOURNAL OF IMMUNOLOGY , vol.7, no.2, pp.102-106, 2019 (ESCI, Scopus, TRDizin)

2019

131. CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease

Ozen A. O.

IMMUNOLOGICAL REVIEWS , vol.287, no.1, pp.20-32, 2019 (SCI-Expanded)

2019

132. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

Kiykim A., Ogulur I., Dursun E., Charbonnier L. M., Nain E., Cekic S., et al.

The journal of allergy and clinical immunology. In practice , vol.7, no.8, 2019 (SCI-Expanded, Scopus)

2019

133. Hematopoietic Stem Cell Transplantation in Patients with Heterozygous STAT1 Gain-of-Function Mutation.

Kiykim A., Charbonnier L. M., Akcay A., Karakoc-Aydiner E., Ozen A. O., Ozturk G., et al.

Journal of clinical immunology , vol.39, no.1, pp.37-44, 2019 (SCI-Expanded, Scopus)

2019

134. Evaluation of a Standardized Bakery Product (SUTMEK) as a Potential Tool for Baked-Milk Tolerance and Immunotherapy Research Studies

Kiykim A., Karakoc-Aydiner E., Gunes E., Nain E., Öğülür İ., Yazici D., et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.178, no.1, pp.1-9, 2019 (SCI-Expanded)

2019

135. Gastrointestinal Manifestations in Children with Primary Immunodeficiencies: Single Center: 12 Years Experience

Akkelle B., Tutar E., Volkan B., Kalaycık Şengül Ö., Ozen A. O., Çelikel Ç., et al.

DIGESTIVE DISEASES , vol.37, pp.45-52, 2019 (SCI-Expanded, Scopus)

2018

136. Group 3 innate Iymphoid cells are absent DOCK8- defective HIES patients

EKEN A., Okuş F. Z., PATIROĞLU T., Erdem Ş., Karakükçü m., CANSEVER M., et al.

Journal Of Immunology , vol.200, pp.17025, 2018 (SCI-Expanded)

2018

137. Dental follicle mesenchymal stem cells down-regulate Th2-mediated immune response in asthmatic patients mononuclear cells.

Genc D., Zibandeh N., Nain E., Gokalp M., Ozen A. O., Goker M. K., et al.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.48, no.6, pp.663-678, 2018 (SCI-Expanded)

2018

138. A Novel Mendelian Disease of Autoimmunity caused byMutations in a small GTPase

Leney Greene M. A., Park A., Chao B., Vilarinho S., Su H., ÖZEN A. O., et al.

Journal Of Immunology , vol.200, pp.45-49, 2018 (SCI-Expanded)

2018

139. Functional reprogramming of regulatory T cells in theabsence of Foxp3

Charbonnier L. M., Lopez D., Bleesing J., Lloret M. G., Chen K., ÖZEN A. O., et al.

Journal Of Immunology , vol.2001, pp.176, 2018 (SCI-Expanded)

2018

140. Ev Tozu Akarı Duyarlı Atopik Dermatitli Çocuklarda D Vitaminin Etkisi

Nain E., KIYKIM A., YAŞÖZ C., BAYRAMLI R., BARIŞ S., ÖZEN A. O., et al.

Astım Allerji İmmünoloji , vol.16, pp.40-46, 2018 (Peer-Reviewed Journal)

2018

141. Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

Maccari M. E., Abolhassani H., Aghamohammadi A., Aiuti A., Aleinikova O., Bangs C., et al.

Frontiers in immunology , vol.9, pp.543, 2018 (SCI-Expanded)

2018

142. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Barzaghi F., Hernandez L. C. A., Neven B., Ricci S., Kucuk Z. Y., Bleesing J. J., et al.

The Journal of allergy and clinical immunology , vol.141, no.3, 2018 (SCI-Expanded, Scopus)

2018

143. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

Béziat V., Li J., Lin J., Ma C., Li P., Bousfiha A., et al.

SCIENCE IMMUNOLOGY , vol.3, 2018 (SCI-Expanded, Scopus)

2018

144. Effects of Vitamin D on House Dust Mite Sensitized Children with Atopic Dermatitis

Nain E., Kiykim A., Yasoz C., Bayramli R., Barış S., Ozen A. O., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.16, no.1, pp.40-46, 2018 (ESCI)

2018

145. Diagnostic Usage of Intracellular Protein Staining by Flow Cytometer in Primary Immune Deficiencies; Marmara Experience

ÖĞÜLÜR İ., BARIŞ S., Ozen A. O., Nain E., Kiykim A., Karakoc-Aydiner E.

ASTIM ALLERJI IMMUNOLOJI , vol.16, no.2, pp.81-89, 2018 (ESCI)

2017

146. LRBA Eksikliği Tanısında Akan Hücre Ölçerde Protein İfadesi

oğulur i., KIYKIM A., Nain E., SOMER A., GÜVEN A., BARIŞ S., et al.

Astım Allerji İmmünoloji , vol.15, pp.123-128, 2017 (Peer-Reviewed Journal)

2017

147. Hematopoietic stem cell transplantation from unrelated donors in children with DOCK8 deficiency

Uygun D. F. K., Uygun V., REİSLİ İ., KELEŞ S., Ozen A. O., YILMAZ M., et al.

PEDIATRIC TRANSPLANTATION , vol.21, no.7, 2017 (SCI-Expanded)

2017

148. DOCK8 and STAT3 dependent inhibition of IgE isotype switching by TLR9 ligation in human B cells

Massaad M. J., Cangemi B., Al-Herz W., LeFranc G., Freeman A., Baxi S., et al.

CLINICAL IMMUNOLOGY , vol.183, pp.263-265, 2017 (SCI-Expanded)

2017

149. CD55 Deficiency and Protein-Losing Enteropathy REPLY

Ozen A. O., Comrie W. A., Lenardo M. J.

NEW ENGLAND JOURNAL OF MEDICINE , vol.377, no.15, pp.1499-1500, 2017 (SCI-Expanded)

2017

150. CD55 Deficiency and Protein-Losing Enteropathy

ÖZEN A. O., Comrie W., Lenardo M.

New England Journal Of Medicine , vol.377, pp.1499-1500, 2017 (SCI-Expanded)

2017

151. Predictive risk factors for relapse after cessation of inhaled corticosteroids in well-controlled childhood asthma

akturk h., Karakoc-Aydiner E., ÖZEN A. O., Baris S., akkoc T., bahceciler n., et al.

MINERVA PEDIATRICA , vol.69, no.4, pp.274-280, 2017 (SCI-Expanded)

2017

152. Serum IgE Düzeyi ve Eozinofil Sayısı ile AtopikHastalıklar Hiper IgE Sendromu’xxndan Ayırt Edilebilir mi?

KIYKIM A., YÜCE E. G., BARIŞ E., Nain E., KELEŞ S., AKTÜRK H., et al.

Astım Allerji İmmünoloji , vol.15, pp.1-9, 2017 (Peer-Reviewed Journal)

2017

153. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis.

Ozen A. O., Comrie W. A., Ardy R. C., Conde C. D., Dalgıç B., Beser O. F., et al.

The New England journal of medicine , vol.377, no.1, pp.52-61, 2017 (SCI-Expanded, Scopus)

2017

154. Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication.

Aghamohammadi A., Hassan A., KÜTÜKÇÜLER N., Wassilak S. G., Pallansch M. A., Kluglein S., et al.

Frontiers in immunology , vol.8, pp.685, 2017 (SCI-Expanded, Scopus)

2017

155. Basophil activation test for inhalant allergens in pediatric patients with allergic rhinitis.

ÖĞÜLÜR İ., Kiykim A., BARIŞ S., Ozen A. O., Yuce E. G., Karakoc-Aydiner E.

International journal of pediatric otorhinolaryngology , vol.97, pp.197-201, 2017 (SCI-Expanded)

2017

156. Protein Expression in the Diagnosis of LRBA Deficiency by Flow Cytometer

ÖĞÜLÜR İ., Kiykim A., Nain E., Somer A., Guven A., BARIŞ S., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.15, no.3, pp.123-128, 2017 (ESCI)

2017

157. Can Atopic Diseases be Differentiated from Hyper IgE Syndrome by Serum IgE and Blood Eosinophil Levels?

Kiykim A., Yuce E. G., Baris E., Nain E., KELEŞ S., Akturk H., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.15, no.2, pp.73-81, 2017 (ESCI)

2017

158. Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite?

Kiykim A., MUMCU G., ÖĞÜLÜR İ., Karakoc-Aydiner E., Direskeneli H., BARIŞ S., et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.174, no.1, pp.52-56, 2017 (SCI-Expanded, Scopus)

2016

159. The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency.

Baris H. E., Kiykim A., Nain E., ÖZEN A. O., Karakoc-Aydiner E., BARIŞ S.

Turk pediatri arsivi , vol.51, no.4, pp.186-192, 2016 (ESCI)

2016

160. Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1

Baris S., Alroqi F., Kiykim A., Karakoc-Aydiner E., ÖĞÜLÜR İ., Ozen A. O., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.36, no.7, pp.641-648, 2016 (SCI-Expanded, Scopus)

2016

161. School Board Policies on Prevention and Management of Anaphylaxis in İstanbul: Where Do We Stand?

ÖZEN A. O., BORAN P., torlak f., Karakoc-Aydiner E., barış s., KARAVUŞ M., et al.

Balkan medical journal , vol.33, no.5, pp.539-542, 2016 (SCI-Expanded)

2016

162. Nijmegen-Breakage Syndrome; Two Siblings Presenting with Different Phenotypes

Kiykim A., AYDINER E., ÖĞÜLÜR İ., BARIŞ S., Ozen A. O., Serifov K., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.14, no.2, pp.98-102, 2016 (ESCI)

2016

163. House Dust Mites Confer a Distinct Immunological Feature among Dermatitis

BARIŞ S., Ozen A. O., Akdeniz T., Karakoc-Aydiner E., Aydin O., ERCAN SARIÇOBAN H., et al.

IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY , vol.15, no.4, pp.264-274, 2016 (SCI-Expanded, Scopus)

2016

164. The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.

Baris H. E., BARIŞ S., Karakoc-Aydiner E., GÖKCE İ., YILDIZ N., Cicekkoku D., et al.

European journal of pediatrics , vol.175, no.5, pp.685-93, 2016 (SCI-Expanded, Scopus)

2016

165. Novel CLPB mutation in a patient with 3-methylglutaconic aciduria causing severe neurological involvement and congenital neutropenia.

Kiykim A., Garncarz W., Karakoc-Aydiner E., Ozen A. O., KIYKIM E., Yesil G., et al.

Clinical immunology (Orlando, Fla.) , vol.165, pp.1-3, 2016 (SCI-Expanded, Scopus)

2016

166. Use of subcutaneous immunoglobulin in primary immune deficiencies

AYDINER E., Kiykim A., BARIŞ S., Ozen A. O., Barlan I.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , vol.51, no.1, pp.8-14, 2016 (ESCI, Scopus, TRDizin)

2016

167. Primary catastrophic antiphospholipid syndrome in an 8 year old girl

BARIŞ H. E., AKSU LİMON Ç., VURAL I., KEPENEKLİ KADAYİFCİ E., KOÇ A., KIYKIM A., et al.

MARMARA MEDICAL JOURNAL , vol.29, no.1, pp.41, 2016 (ESCI)

2016

168. Two patients with novel missense mutation in the purine nucleoside phosphorylase gene without serious or recurrent infections

Kiykim A., Simsek I. E., Kiykim E., Karakoc-Aydiner E., BARIŞ S., ÖZEN A. O., et al.

Clinical and Experimental Neuroimmunology , vol.7, no.1, pp.79-82, 2016 (SCI-Expanded)

2016

169. Vitamin B12 deficiency among asymptomatic healthy infants: its impact on the immune system.

BORAN P., yildirim s., Karakoc Aydiner E., Ogulur I., ÖZEN A. O., Haklar G., et al.

Minerva pediatrica , 2016 (SCI-Expanded, Scopus)

2015

170. G6PC3 Deficiency: Primary Immune Deficiency Beyond Just Neutropenia

Kiykim A., BARIŞ S., Karakoc-Aydiner E., ÖZEN A. O., ÖĞÜLÜR İ., Bozkurt S., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.37, no.8, pp.616-622, 2015 (SCI-Expanded, Scopus)

2015

171. Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.

Demirca B. P., Cagan H., Kiykim A., Arig U., Arpa M., Tulunay A., et al.

Respiratory medicine , vol.109, no.9, pp.1120-5, 2015 (SCI-Expanded, Scopus)

2015

172. Glucocorticoid Receptor-beta Is Downregulated by Vitamin D Treatment in Children with Low Vitamin D Levels but Not in Allergic Asthma

Guner S. N., Sancak R., Gulten S., Ozen A. O., Kilic M., BEDİR A.

PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY , vol.28, no.3, pp.144-151, 2015 (SCI-Expanded)

2015

173. Evaluation of Hyperimmunoglobulin M Syndrome by Flow Cytometry

Cinar S., Gelmez M. Y., BARIŞ S., AYDINER E., ÖZEN A. O., Akturk H., et al.

TURKISH JOURNAL OF IMMUNOLOGY , vol.3, no.2, pp.64-70, 2015 (ESCI)

2015

174. Dihidrorhodamin Testi ile Oksidatif Patlama Sağlıklı KontrollerdeReferans Değerleri

ÇİÇEKKÖKÜ D., ÖĞÜLÜR İ., AYDINER E., BARIŞ S., KIYKIM A., ÖZEN A. O., et al.

Turk J Immunol , 2015 (Peer-Reviewed Journal)

2015

175. Ev Tozu Akarı duyarlı Astımlı çocuklarda Subkutan Allerjen İmmünoterapi üzerine D Vitaminin etksis The effect of Vitamin D supplementation on subcutaneous allergen immunotherapy in house dust mite sensitive asthmatic children

ÇINAR S., GELMEZ M. Y., Safa B., AYDINER E., ÖZEN A. O., Hacer A., et al.

Turk J Immunol , 2015 (Peer-Reviewed Journal)

2015

176. The Effect of Vitamin D Supplementation on Subcutaneous Allergen Immunotherapy in House Dust Mite Sensitive Asthmatic Children

Baris S., Ozen A. O., Cagan H., Kiykim A., Tulunay A., Karakoc-Aydiner E., et al.

TURKISH JOURNAL OF IMMUNOLOGY , vol.3, no.2, pp.54-63, 2015 (ESCI)

2015

177. Hiperimmünglobulin M sendromunun akan hücre ölçer ile değerlendirilmesi Evaluation of Hyperimmunoglobulin M syndrome by flow cytometry

ÇINAR S., GELMEZ M. Y., Safa B., AYDINER E., ÖZEN A. O., Hacer A., et al.

Turk J Immunol , 2015 (Peer-Reviewed Journal)

2015

178. Oxidative Burst with Dihydrorhodamine Test: Reference Values in Healthy Controls

Cicekkoku D., ÖĞÜLÜR İ., Karakoc-Aydiner E., BARIŞ S., Kiykim A., Ozen A. O., et al.

TURKISH JOURNAL OF IMMUNOLOGY , vol.3, no.2, pp.49-53, 2015 (ESCI)

2015

179. Dihidrorodamin testi ile oksidatif patlama Sağlıklı kontrollerde referans değerleri Oxidative burst with Dihyrrhodamine test Reference values in healthy controls

Dilek Ç., ÖĞÜLÜR İ., AYDINER E., Safa B., ÖZEN A. O., Işıl B.

Turk J Immunol , 2015 (Peer-Reviewed Journal)

2015

180. Potentially Beneficial Effect of Hydroxychloroquine in a Patient with a Novel Mutation in Protein Kinase Cδ Deficiency.

Kiykim A., ÖĞÜLÜR İ., BARIŞ S., Salzer E., Karakoc-Aydiner E., ÖZEN A. O., et al.

Journal of clinical immunology , vol.35, no.6, pp.523-6, 2015 (SCI-Expanded, Scopus)

2015

181. Experience of influenza A H1N1 in a paediatric emergency unit

Bicer s., Ercan h., ÖZEN A. O., saf c., ergenekon p., gurol y., et al.

Le Infezioni In Medicina , 2015 (Peer-Reviewed Journal)

2015

182. JAGN1 Deficient Severe Congenital Neutropenia: Two Cases from the Same Family.

Baris S., Karakoc-Aydiner E., Ozen A. O., Delil K., Kiykim A., Ogulur I., et al.

Journal of clinical immunology , vol.35, no.4, pp.339-43, 2015 (SCI-Expanded, Scopus)

2015

183. Atypical presentation of Takayasu's arteritis in an adolescent

Binnetoglu K. K., Karakoc Aydiner E., BARIŞ S., Ozen A. O., Zohre A. I., BALTACIOĞLU F., et al.

MARMARA MEDICAL JOURNAL , vol.28, no.3, pp.157-160, 2015 (ESCI)

2015

184. Food Protein-Induced Non-Immunoglobulin E-Mediated Allergic Colitis in Infants and Older Children: What Cytokines Are Involved?

ÖZEN A. O., Gulcan E. M., Sarıcoban H. E., Ozkan F., Cengizlier R.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.168, no.1, pp.61-68, 2015 (SCI-Expanded)

2015

185. Early-onset neurolupus: A challenge for pediatricians

BARIŞ S., Karakoc-Aydiner E., Ozen A. O., Kacmaz M., Namar M., YILDIZ N., et al.

MARMARA MEDICAL JOURNAL , vol.28, no.2, pp.105-108, 2015 (ESCI, Scopus, TRDizin)

2014

186. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K

Lucas C. L., Zhang Y., Venida A., Wang Y., Hughes J., McElwee J., et al.

JOURNAL OF EXPERIMENTAL MEDICINE , vol.211, no.13, pp.2537-2547, 2014 (SCI-Expanded)

2014

187. Clinical Heterogeneity of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked: Pulmonary Involvement as a Non-Classical Disease Manifestation

BARIŞ S., Schulze I., Ozen A. O., AYDINER E., Altuncu E., Karasu G. T., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.34, no.6, pp.601-606, 2014 (SCI-Expanded, Scopus)

2014

188. Kronik granülomatöz hastalıklı olgularımızın değerlendirilmesi

BARIŞ S., ÖZEN A. O., KIYKIM A., onat e. g., AYDINER E., BARLAN I.

ASTIM ALLERJI IMMUNOLOJI , pp.26-34, 2014 (Peer-Reviewed Journal)

2014

189. The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis

Karatepe H. O., Kilincaslan H., Berber M., Ozen A., Saricoban H. E., Ustek D., et al.

PEDIATRIC SURGERY INTERNATIONAL , vol.30, no.3, pp.327-332, 2014 (SCI-Expanded)

2014

190. Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite.

Baris S., Kiykim A., Ozen A. O., Tulunay A., Karakoc-Aydiner E., Barlan I. B.

Allergy , vol.69, no.2, pp.246-53, 2014 (SCI-Expanded, Scopus)

2014

191. Alteration in humoral immunity is common among family members of patients with common variable immunodeficiency.

Karakoc-Aydiner E., ÖZEN A. O., Bans S., ercan h., ozdemir c., barlan i. b.

Journal of investigational allergology & clinical immunology , vol.24, no.5, pp.346-51, 2014 (SCI-Expanded)

2014

192. The evaluation of our patients with chronic granulomatous disease

BARIŞ S., ÖZEN A. O., KIYKIM A., Onat E. G., Aydiner E., Barlan I.

ASTIM ALLERJI IMMUNOLOJI , vol.12, no.1, pp.26-34, 2014 (ESCI, TRDizin)

2013

193. Risk factors for persistence of asthma in children: 10-year follow-up

Aydogan M., Ozen A. O., AKKOÇ T., Eifan A. O., Aktas E., Deniz G., et al.

JOURNAL OF ASTHMA , vol.50, no.9, pp.938-944, 2013 (SCI-Expanded)

2013

194. Urinary stone disease in the first year of life: is it dangerous?

ALPAY H., GÖKCE İ., Ozen A. O., Biyikli N.

PEDIATRIC SURGERY INTERNATIONAL , vol.29, no.3, pp.311-316, 2013 (SCI-Expanded)

2013

195. Predictors of atopic dermatitis phenotypes and severity: Roles of serum immunoglobulins and filaggrin gene mutation R501X

Ercan H., Ispir T., Kirac D., Baris S., Ozen A. O., Oztezcan S., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.41, no.2, pp.86-93, 2013 (SCI-Expanded)

2012

196. Impact of early weight loss on growth of Caesarean delivered babies: how long does it last?

BAKAR F., ÖZEN A. O., Karatepe H. O., Berber M., Ercan H.

CHILD CARE HEALTH AND DEVELOPMENT , vol.38, no.5, pp.706-713, 2012 (SCI-Expanded)

2012

197. Primary school teachers' knowledge about and attitudes toward anaphylaxis

ercan h., ÖZEN A. O., karatepe h., berber m., cengizlier r.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.23, no.5, pp.428-432, 2012 (SCI-Expanded)

2012

198. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis

Ozen A. O., BARIŞ S., AYDINER E., Yucelten D., Bahceciler N. N.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.40, no.2, pp.131-133, 2012 (SCI-Expanded, Scopus)

2011

199. Prognostic factors in rotavirus and adenovirus gastroenteritis: Which tests are predictive? Rotavirüs ve adenovirüs gastroenteritinde prognostik belirteçler: Hangi testler yol gösterici?

Ercan Sariçoban H., Özen A. O., Bakar F., Karatepe H. Ö., Berber M., Gülcan E. M., et al.

Turkiye Klinikleri Pediatri , vol.20, no.4, pp.267-274, 2011 (Scopus)

2011

200. Osteoporosis: An ignored complication of CVID

BARIŞ S., Ozen A. O., ERCAN SARIÇOBAN H., Karakoc-Aydiner E., Cagan H., Ozdemir C., et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.22, no.7, pp.676-683, 2011 (SCI-Expanded, Scopus)

2011

201. A novel approach in allergen-specific immunotherapy: Combination of sublingual and subcutaneous routes

Keles S., Karakoc-Aydiner E., Ozen A. O., Izgi A. G., Tevetoglu A., AKKOÇ T., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , vol.128, no.4, pp.808-822, 2011 (SCI-Expanded)

2011

202. Serum immunoglobulin levels as a predictive factor for a better outcome of non-atopic childhood asthma

BARIŞ S., Karakoc-Aydiner E., Ozen A. O., Ozdemir C., Bahceciler N. N., Barlan I. B.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.22, no.3, pp.298-304, 2011 (SCI-Expanded)

2011

203. Common behavioral problems among children with asthma: Is there a role of asthma treatment?

Saricoban H. E., ÖZEN A. O., Harmanci K., Razi C., Zahmacioglu O., Cengizlier R.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , vol.106, no.3, pp.200-204, 2011 (SCI-Expanded)

2011

204. A rare cause of claudication: Primary pyomyositis Yürüyememenin nadir bir nedeni: Primer piyomiyozit

Sariçoban H. E., Özen A. O., Uluçay Ç., Ulutaş A. P., Vitrinel A.

Cocuk Enfeksiyon Dergisi , vol.5, no.1, pp.19-21, 2011 (SCI-Expanded)

2011

205. The Effect of Helicobacter Pylori and Economic Status on Growth Parameters and Leptin, Ghrelin, and Insulin-Like Growth Factor (IGF)-I Concentrations in Children

ÖZEN A. O., Furman A., Berber M., Karatepe H., Mutlu N., Saricoban H. E., et al.

HELICOBACTER , vol.16, no.1, pp.55-65, 2011 (SCI-Expanded)

2011

206. Efficacy of Intravenous Immunoglobulin Treatment in Children with Common Variable Immunodeficiency

BARIŞ S., ercan h., cagan h., ÖZEN A. O., Karakoc-Aydiner E., Ozdemir C., et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY , vol.21, no.7, pp.514-521, 2011 (SCI-Expanded, Scopus)

2011

207. Relationship Between Migraine Type Headache in Childhood with Cow s Milk Allergy and Egg white Allergy

ÖZEN A. O., Ercan Saricoban H., Mutlu N., Cengizlier R.

AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY , vol.23, pp.174-178, 2011 (Scopus)

2010

208. Outcome of hypogammaglobulinemia in children: Immunoglobulin levels as predictors

ÖZEN A. O., Baris S., Karakoc-Aydiner E., Ozdemir C., Bahceciler N., Barlan I.

CLINICAL IMMUNOLOGY , vol.137, no.3, pp.374-383, 2010 (SCI-Expanded, Scopus)

2010

209. Impact of H. Pylori on Growth: Is the Infection or Mucosal Disease Related to Growth Impairment?

Gulcan M., ÖZEN A. O., Karatepe H. O., Gulcu D., Vitrinel A.

DIGESTIVE DISEASES AND SCIENCES , vol.55, no.10, pp.2878-2886, 2010 (SCI-Expanded, Scopus)

2010

210. Evaluation of the weight estimation formulae in childhood used frequently Çocuklarda sik kullanilan aǧirlik tahmin formüllerinin uygunluǧunun deǧerlendirilmesi

Biçer S., Özen A. O., Vitrinel A.

Turkiye Klinikleri Pediatri , vol.19, no.3, pp.197-202, 2010 (Scopus)

2010

211. Ambulatory Blood Pressure Monitoring in Children with VUR: Do Microalbuminuria Levels Correlate with Changes in Blood Pressure?

Kilinc A., Alpay H., Gokce İ., Biyikli N., Benzer M., Ozen A. O.

PEDIATRIC NEPHROLOGY , vol.25, no.9, pp.1952, 2010 (SCI-Expanded)

2010

212. Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: 'Similarities and differences'

Keles S., Artac H., Kara R., Gokturk B., ÖZEN A. O., Reisli I.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.21, no.5, pp.843-851, 2010 (SCI-Expanded)

2010

213. Coagulation markers in stroke patients: worth ordering in the emergency department?

Sarikaya S., Karcioglu O., Aktas C., Ay D., ÖZEN A. O., Cetin A.

HEALTHMED , vol.4, no.4, pp.978-982, 2010 (SCI-Expanded)

2010

214. CASE REPORT OF TWO PARAPHARYNGEAL ABSCESS PATIENTS PRESENTED WITH TORTICOLLIS MEDICAL OR SURGICAL TREATMENT?

ÖZEN A. O., Saricoban H. E., Berber M., Karatepe H. O., Bakar F., Cengizlier R., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.73, no.1, pp.23-26, 2010 (ESCI)

2010

215. Bloom syndrome: presentation of two siblings

BARIŞ S., AYDINER E., ÖZEN A. O., ÖZDEMİR C., Bahceciler N. N., Barlan I. B.

ASTIM ALLERJI IMMUNOLOJI , vol.8, no.1, pp.64-68, 2010 (ESCI)

2009

216. Treatment of telangiectasia macularis eruptiva perstans with montelukast

Cengizlier R., Hucumenoglu S., ÖZEN A. O., Sayli T.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.37, no.6, pp.334-336, 2009 (SCI-Expanded)

2009

217. Clinical and metabolic features of urolithiasis and microlithiasis in children

ALPAY H., ÖZEN A. O., Gokce İ., Biyikli N.

PEDIATRIC NEPHROLOGY , vol.24, no.11, pp.2203-2209, 2009 (SCI-Expanded)

2009

218. Effect of Occupation and Smoking on Respiratory Symptoms in Working Children

Cakir E., Uyan Z. S., Varol N., Ay P., Ozen A. O., Karadag B. T., et al.

AMERICAN JOURNAL OF INDUSTRIAL MEDICINE , vol.52, no.6, pp.471-478, 2009 (SCI-Expanded)

2008

219. The prevalence of Helicobacter pylori infection in school children and relationship with nutritional anthropometric indices

ÖZEN A. O., Berber M., Karatepe H. O., Ercan H., Mutlu N., Bakar F., et al.

ACTA PAEDIATRICA , vol.97, pp.52, 2008 (SCI-Expanded)

2008

220. Prevalence and features of migraine and episodic headache in Turkish children and relationship with anthropometry and H-pylori infection

ÖZEN A. O., Berber M., Karatepe H. O., Saricoban H. E., Mutlu N., Bakar F., et al.

ACTA PAEDIATRICA , vol.97, pp.49, 2008 (SCI-Expanded)

2007

221. Ultrasound bone density measurements of prepubertal and pubertal children and factors determining bone mineral density Prepubertal ve pubertal dönemdeki çocuklarin ultrasonometrik kemik yoǧunluǧunun ölçülmesi ve bunu belirleyen faktörlerin deǧerlendirilmesi

Özen A. O., Mustafa B., Şen N., Sariçoban H. E., Büyükgebiz B.

Cocuk Sagligi ve Hastaliklari Dergisi , vol.50, no.4, pp.231-235, 2007 (Scopus)

2007

222. Pediatric stone disease in the first year of life: a single center study

Gokce İ., Alpay H., Biyikli N., Ozen A. O., Moula K.

PEDIATRIC NEPHROLOGY , vol.22, no.9, pp.1534, 2007 (SCI-Expanded)

2007

223. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children.

Turan S., Bereket A., Furman A., Omar A., Berber M., Ozen A., et al.

European journal of clinical nutrition , vol.61, no.6, pp.752-8, 2007 (SCI-Expanded)

2006

224. Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection.

Ozen A. O., Ertem D., Pehlivanoglu E.

Journal of pediatric gastroenterology and nutrition , vol.42, pp.398-404, 2006 (SCI-Expanded, Scopus)

2006

225. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: Establishment of reference ranges with emphasis on puberty

Bereket A., Turan S., Omar A. O., Berber M.

Hormone Research , vol.65, no.2, pp.96-105, 2006 (SCI-Expanded)

2006

226. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: Establishment of reference ranges with emphasis on puberty

BEREKET A., TURAN S., Omar A., Berber M., ÖZEN A. O., Akbenlioglu C., et al.

Hormone Research , vol.65, no.2, pp.96-105, 2006 (SCI-Expanded, Scopus)

2006

227. Factors related to childhood obesity

Bereket A., Turan S., Omar A., Berber M., Ozen A. O.

HORMONE RESEARCH , vol.65, pp.82, 2006 (SCI-Expanded)

2005

228. Upper segment/lower segment ratio and armspan-height difference in healthy Turkish children

Turan S., Bereket A., Omar A., Berber M., Ozen A. O., Bekiroglu N.

ACTA PAEDIATRICA , vol.94, no.4, pp.407-413, 2005 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences

1. Within-Trial Interviews to Contextualize the Patient Experience and Supplement Clinical Outcomes Assessments in a Pivotal Trial of a Newly Described, Fatal and Ultra-Rare Pediatric Disease

Litcher-Kelly L., ÖZEN A. O., Ollis S., Baris-Feldman H., Yaworsky A., Medrano P., et al.

vol.33, pp.655, (Summary Text)

2024

2. Yaygın Değişken İmmün Yetersizliklerde Tüm Genom Metilasyon Değişimlerinin İncelenmesi

Işıkgil B., BİLGİÇ ELTAN S., ERBİLGİN Y., KUTLU A., GEMİCİ KARAASLAN H. B., ÖZEK E., et al.

10. KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Turkey, 15 April 2024, (Summary Text)

2023

3. Recombinase activating gene defects, phenotypic diversity

ŞADIRVAN OĞUZKAYA Y. H., ÇEKİÇ Ş., YORĞUN ALTUNBAŞ M., KARALI Z., AYDINER E., ÖZEN A. O., et al.

EAACI congress, 12 December 2023, (Summary Text)

2023

4. Doğuştan Gelen Bağışıklık Kusurlarında T Hücre Plastisitesi ve Hedeenmiş Tedavi Seçenekleri ile Değişimi

Bayram Çatak F., çatak m. c., BULUTOĞLU A., YORĞUN ALTUNBAŞ M., BABAYEVA R., KARABİBER E., et al.

29. ULUSAL ALERJİ VE KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Turkey, 29 November 2023, vol.1, pp.287, (Full Text)

5. A phase 2/3 study evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE disease)

Ozen A. O., Chongsrisawat V., Sefer A., Kolukisa B., Jalbert J., Miller J., et al.

vol.228, pp.9, (Summary Text)

2023

6. Egzamada atipik lokalizasyon Hiper IgE sendromunu atopik dermatitten ayırt eder

Kasap N., KARA A., ÇELİK V., BİLGİÇ ELTAN S., AKAY HACI İ., KÖSE H., et al.

9. Klinik İmmünoloji Kongresi, Antalya, Turkey, 1 - 04 May 2023, pp.32-33, (Summary Text)

7. EVALUATING THE PATIENT EXPERIENCE WITH CD55 DEFICIENCY WITH HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY (CHAPLE) DISEASE: A DEADLY ULTRARARE PEDIATRIC DISEASE

Litcher-Kelly L., Ollis S., Yaworsky A., Feldman H., Harari O., Ozen A. O., et al.

vol.26, (Summary Text)

8. A Rare Immunodeficiency As a Cause of Inflammatory Bowel Disease; ARPC1B Deficiency

Sefer A., Can S., Bulutoglu A., Baser D., Islek A., Altintas D., et al.

vol.250, pp.142, (Summary Text)

2022

9. Güncel Bilgiler Işığında CHAPLE Hastalığının Doğal Öyküsü, Epidemiyolojik Özellikleri ve Tedavi Yanıtlarının Değerlendirilmesi

CEVAHİR Ş., AYDOĞDU E. S., SELÇUK M., SEFER A. P., YORĞUN ALTUNBAŞ M., YALÇIN GÜNGÖREN E., et al.

7. Genç Pediatristler Kongresi/4th Congress of Paediatric Association of the Balkan-İstanbul, 2 - 04 December 2022, (Full Text)

2022

10. Allergic Diseases in Children with Behavioral Insomnia of Childhood

TORUN T., BARIŞ H. E., ÖZBÖRÜ AŞKAN Ö., ÖZEN A. O., BARIŞ S., AYDINER E., et al.

3rd International Eurasian Congress of Social Pediatrics& 7th National Congress of Social Pediatrics, İzmir, Turkey, 16 - 20 November 2022, (Summary Text)

2022

11. Delayed Umbilical Cord Separation and Associated Factors

AYGÜN B., BARIŞ H. E., BARIŞ S., ÖZEN A. O., AYDINER E., BORAN P.

3rd International Eurasian Congress of Social Pediatrics& 7th National Congress of Social Pediatrics, İzmir, Turkey, 16 - 20 November 2022, (Summary Text)

2022

12. YAYGIN DEĞİŞKEN İMMÜN YETMEZLİK HASTALARINDA PATOJENİK OLMAYAN TNFRSF13B KIRPILMA VARYANTLARININ KLİNİK BULGULAR İLE İLİŞKİSİ

Işıkgil B., YİLMAZ H., NG Y. Y., HATIRNAZ NG Ö., KIYKIM A., OZEK E., et al.

8. Klinik İmmünoloji Kongresi, Turkey, 26 - 29 October 2022, (Summary Text)

2022

13. LRBA VE CTLA4 EKSIKLIGI OLAN HASTALARDA CTLA-4 E BAGLI BIYOLOJIK KUSUR DUZEYLERININ KARSILASTIRILMASI

catak m. c., AKCAM CELIK B., BİLGİÇ ELTAN S., BABAYEVA R., BAYRAM F., KARAKUS I. S., et al.

8. KLINIK IMMUNOLOJI KONGRESI, Antalya, Turkey, 26 - 29 October 2022, (Summary Text)

2022

14. F373A Mutasyonu ve IPEX: Klasik Prezantasyon Her Zaman Olmayabilir

BEKİS BOZKURT H., BİLGİÇ ELTAN S., BABAYEVA R., YORĞUN ALTUNBAŞ M., SEFER A. P., ÖZEN A. O., et al.

8. KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Turkey, 26 - 29 October 2022, (Full Text)

2022

15. LRBA ve CTLA-4 Eksikliği Olan Hastalarda CTLA-4’e Bağlı Biyolojik Kusur Düzeylerinin Karşılaştırılması

ÇATAK M. C., AKÇAM B., BİLGİÇ ELTAN S., BABAYEVA R., BAYRAM F., KARAKUŞ İ. S., et al.

8. Klinik İmmünoloji Kongresi-Antalya, 26 - 29 October 2022, (Summary Text)

2022

16. Recombinase activating gene defects, phenotypic diversity: Two centers’ experience from Turkey

ŞADIRVAN OĞUZKAYA Y. H., ÇEKİÇ Ş., YORĞUN ALTUNBAŞ M., KARALI Z., AYDINER E., ÖZEN A. O., et al.

20th Biennial Meeting 2022, Sweden, 12 October 2022, (Summary Text)

17. Evaluation of radiosensitivity and DNA repair with Comet test in patients with STAT3-LOF and ZNF341 deficiency

ÇEKİÇ Ş., Huriyet H., BEKTAŞ HORTOĞLU M., ÖZEN A. O., Aydiner E., DEMİRÖZ ABAKAY C., et al.

vol.52, pp.258-259, (Summary Text)

2022

18. BESİN ALERJİSİ OLAN ÇOCUKLARDA YAŞAM KALİTESİ VE TEDAVİ MEMNUNİYETİNİN DEĞERLENDİRİLMESİ

GÜNAL Ö., SEFER A. P., ÜTÜK B., BİLGİÇ ELTAN S., YORĞUN ALTUNBAŞ M., BARIŞ S., et al.

57. TÜRK PEDİATRİ KONGRESİ, Turkey, 22 May 2022, pp.307-310, (Full Text)

2022

19. ÇOCUKLUK ÇAĞI DAVRANIŞSAL İNSOMNİSİNDE ALLERJEN DUYARLILIK VE HASTALIK SIKLIĞI

TORUN T., BARIŞ H. E., ÖZBÖRÜ AŞKAN Ö., ÖZEN A. O., BARIŞ S., AYDINER E., et al.

57. TÜRK PEDİATRİ KONGRESİ, Cyprus (Kktc), 22 - 26 May 2022, (Summary Text)

2022

20. Futbol Spor Okulu Öğrencilerinde Dijital Oyun Bağımlılığı, Dikkat ve Reaksiyon Zamanı Arasındaki İlişkinin İncelenmesi

Özen A. O., ERSÖZ G., AKTUĞ Z. B.

VI. Uluslararası Egzersiz ve Spor Psikolojisi Kongresi, Antalya, Turkey, 11 - 13 May 2022, (Summary Text)

2021

21. Primer İmmün Yetmezlikli Hastalarda COVID-19 Seyri; Alt Sınıflar Arasında Eşitsizlik Var

BİLGİÇ ELTAN S., Babayeva R., AYDINER Ö., KEPENEKLİ KADAYİFCİ E., Kolukısa B., SEFER A. P., et al.

28. Ulusal Allerji ve Klinik immünoloji Kongresi, 13 - 17 October 2021, (Summary Text)

2021

22. Protein Kaybettirici Enteropatilere Güncelleme: CD55 Düşüklüğü Olan ve Olmayan Tiplerin Klinik Özellikleri ve Tedavi Yanıtları

SELÇUK M., SEFER YILMAZ A. P., BAŞER D., YALÇIN GÜNGÖREN E., KOCAMIŞ B., DURSUN E., et al.

7. Klinik İmmünoloji Kongresi, 6 - 09 October 2021, (Summary Text)

2021

23. The Effects of Abatacept in Patient with LRBA Deficiency and CTLA4 Immunodeficiency

CATAK M. C., BABAYEVA R., BİLGİÇ ELTAN S., BASER D., AKGUN G., BULUTOGLU A., et al.

ESID 2021 Meeting on Secondary Immunodeficiencies, organised by the Clinical Working Party, 27 - 29 September 2021, (Summary Text)

2021

24. THE EFFECTS OF ABATACEPT IN PATIENTS WITH LRBA DEFICIENCY AND CTLA4 INSUFFICIENCY

çatak m., babayeva r., BİLGİÇ ELTAN S., başer d., akgün g., a b., et al.

VIRTUAL ESID meeting, ESID Clinical Working Party 2021, 27 - 29 September 2021, pp.21-22, (Full Text)

2021

25. Complex Immune Alterations in CHAPLE Disease with or without Complement C5-Inhibition Therapy

ÖZEN A. O., KASAP N., KARAKOÇ AYDINER E., BARIŞ S., HARARI O., LENARDO M.

ESID 2021 Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies, 27 - 29 September 2021, (Summary Text)

2021

26. Natural History and Immune Profiles in CD55-Deficient or CD55 Sufficient Protein Losing Enteropathies

SELÇUK M., SEFER A. P., BAŞER D., ÖĞÜLÜR İ., BİLGİÇ ELTAN S., DURSUN E., et al.

ESID 2021 Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies, 27 - 29 September 2021, (Summary Text)

2021

27. Adverse COVID Outcomes in Youngsters with Immune Deficiencies;Inequality Exists Between Subclasses

AYDINER E., BİLGİÇ ELTAN S., Babayeva R., AYDINER Ö., KEPENEKLİ KADAYİFCİ E., Kolukısa B., et al.

6th European Congress of Immunology, 1 - 04 September 2021, (Summary Text)

2021

28. CHAPLE Disease and Non‐CHAPLE Protein Losing Enteropathies: Natural History and İmmune Characteristics

SELÇUK M., SEFER A. P., BAŞER D., ÖĞÜLÜR İ., BİLGİÇ ELTAN S., DURSUN E., et al.

6th European Congress of Immunology, 1 - 04 September 2021, (Summary Text)

2021

29. REVERSAL CLINICAL AND IMMUNOLOGICAL EFFECTS OF ABATECEPT IN PATIENTS WITH LRBA and CTLA4 DEFICIENCIES

BARIŞ S., BABAYEVA R., catak m. c., BASER D., BİLGİÇ ELTAN S., AKGUN G., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY, 1 - 04 September 2021, vol.51, pp.77, (Summary Text)

2021

30. The evaluation of radiosensitivity in patients with STAT3 deficiency

ÇEKİÇ Ş., Huriyet H., Hortoglu M. B., BARIŞ S., METİN A., ÖZEN A. O., et al.

the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference, 14 April 2021, (Summary Text)

2021

31. CARMIL2 Deficiency and Various Clinical Phenotypes: Warning Signs for Early Diagnosis

KOCAMIŞ KOLUKISA B., KASAP N., BİLGİÇ ELTAN S., BAŞER D., AKGÜN G., SEFER DEMİRKOL A. P., et al.

12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference, 14 - 17 April 2021, (Summary Text)

2020

32. immün disregülasyonhastalık modeli olan lrba ve ctla4 eksikliği olgularında soluble cd25 ve foliküler t hücrelerin hastalık aktivitesini göstermedeki rolü

akçam b., ÖĞÜLÜR İ., akgün g., başer d., karakuş i. s., bayram f., et al.

6. klinik immünoloji kongresi, İstanbul, Turkey, 31 October 2020, pp.120-121, (Summary Text)

2020

33. IMMUN DISREGULASYON HASTALIK MODELI OLAN LRBA VE CTLA-4 EKSIKLIGI OLGULARINDA SOLUABLE CD25 VE FOLIKULER T HUCRELERIN HASTALIK AKTIVITESINI GOSTERMEDEKI ROLU

AKCAM B., ÖĞÜLÜR İ., AKGUN G., BASER D., KARAKUS I. S., BAYRAM F., et al.

6. Klinik Immunoloji Kongresi, 31 October - 01 November 2020, (Summary Text)

2020

34. LRBA VE CTLA-4 EKSIKLIKLERININ TANISINDA VE AYRIMINDA FLOW SITOMETRININ YERI

AKCAM CELIK B., ÖĞÜLÜR İ., AKGUN G., BASER D., KARAKUS I. S., BAYRAM F., et al.

6. Klinik Immunoloji Kongresi, 31 October - 01 November 2020, (Summary Text)

2020

35. LRBA VE CTLA4EKSİKLİKLERİNİN TANISINDA VE AYIRIMDA AKIM SİTOMETRİNİN YERİ

akçam b., ÖĞÜLÜR İ., akgün g., başer d., karakuş i. s., bayram f., et al.

6. klinik immünoloji kongresi, İstanbul, Turkey, 31 October 2020, pp.117-118, (Summary Text)

2020

36. LBRA ve CTLA-4 Eksikliklerinin Tanısında ve Ayrımında Flow Sitometrinin Yeri

AKÇAM B., ÖĞÜLÜR İ., AKGÜN G., KARAKUŞ İ. S., CAN Y., KASAP N., et al.

6.Klinik İmmünoloji Kongresi, Turkey, 31 October 2020, (Full Text)

2020

37. CARMIL2 Eksikliği ve Klinikte Gözlenen Farklı Fenotipleri: Erken Tanı İçin Uyarıcı Bulgular

KOCAMIŞ B., KASAP N., BİLGİÇ ELTAN S., BAŞER D., AKGÜN G., KARAKOÇ AYDINER E., et al.

6. Klinik İmmünoloji Kongresi, 31 October - 01 November 2020, (Summary Text)

2020

38. İmmün disregülasyon hastalık modeli olan LRBA ve CTLA4 eksikliği olgularında solubleCD25 ve foliküler T hücrelerin hastalık aktivitesini göstermedeki rolü

AKÇAM B., ÖĞÜLÜR İ., AKGÜN G., KARAKUŞ İ. S., CAN Y., KASAP N., et al.

6.Klinik İmmünoloji Kongresi, Turkey, 31 October 2020, (Full Text)

2020

39. CHAPLE Hastalığında Düzenleyici T Hücrelerin ve Sitokin Üretim Profillerinin Belirlenmesi

BAŞER D., SELÇUK M., BARIŞ S., AKGÜN G., KASAP N., KARAKOÇ AYDINER E., et al.

6. Klinik İmmünoloji Kongresi, 31 October - 01 November 2020, (Summary Text)

2020

40. İmmunoglobulin Replasman Tedavi Yöntemlerine Hasta Yaklaşımları, Marmara Deneyimi

KOCAMIŞ B., KASAP N., BİLGİÇ ELTAN S., BARIŞ S., ÖZEN A. O., KARAKOÇ AYDINER E.

6. Klinik İmmünoloji Kongresi, 31 October - 01 November 2020, (Summary Text)

2020

41. Yaygın Değişken İmmün Yetmezlik Modeli Olarak TACI Eksikliğinin Farklı Klinik Spektrumu

SEFER YILMAZ A. P., KASAP N., KEREN M., KENDİR Y., BİLGİÇ ELTAN S., KOCAMIŞ B., et al.

6. Klinik İmmünoloji Kongresi, 31 October - 01 November 2020, (Summary Text)

2020

42. Broadly Effective Metabolic And Immune Recovery With C5 inhibition in CHAPLE Disease.

ÖZEN A. O., ÖĞÜLÜR İ., BARIŞ S., AYDINER E.

19th Biennial Meeting of The European Society for Immunodeficiencies., Birmingham, United Kingdom, 14 - 16 October 2020, (Full Text)

2020

43. diagnostic modalities based on flow cytometry for lrba and ctla4 deficiencies; a multicenter study

akçam b., ÖĞÜLÜR İ., akgün g., başer d., can y., bayram f., et al.

esid 2020, England, 14 October 2020, pp.102-103, (Summary Text)

2020

44. EXTENDED CLINICAL AND IMMUNOLOGICAL PHENOTYPE AND TRANSPLANT OUTCOME INCD27 AND CD70 DEFICIENCY

GHOSH S., Bal S. K., EDWARDS E. J., HEREDİA JİMENEZ R., PİLLAY B., ÇİPE F., et al.

19. Biennial Meeting of ESID, ONLİNE, United Kingdom, 14 - 17 October 2020, (Full Text)

2020

45. Dramatic metabolic recovery following precision therapy of CHAPLE syndrome.

ÖZEN A. O., ŞAHİN AKKELLE B., ÖĞÜLÜR İ., GÜNER Ş. N., AYDINER E., BARIŞ S., et al.

World Immune Regulation Meeting. Dramatic metabolic recovery following precision therapy of CHAPLE syndrome., DAVOS, Switzerland, 04 October 2020, (Full Text)

2020

46. PGM3 Deficiency: A New Spectrum of Phenotypes

Durkee-Shock J., Fisher M., Padem N., Makhija M., Ozen A., Alsina L., et al.

Annual Meeting of the Clinical-Immunology-Society (CIS) / Immune Deficiency and Dysregulation North American Conference, Colorado, United States Of America, 2 - 05 April 2020, vol.40, (Summary Text)

2020

47. Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome

Labrosse R., Chu J., Armant M., Van der Spek J., Miggelbrink A., Fong J., et al.

Annual Meeting of the Clinical-Immunology-Society (CIS) / Immune Deficiency and Dysregulation North American Conference, Colorado, United States Of America, 2 - 05 April 2020, vol.40, (Summary Text)

2020

48. PRİMER İMMÜN YETMEZLİK HASTA VE SAĞLIKLI BİREYLERDE TREC/KREC KOPYA SAYILARININ ANALİZİ VE KULLANIMI

Şentürk G., NG Y. Y., ERTAN S. B., ÖĞÜLÜR İ., KIYKIM A., ÖZEN A. O., et al.

1st Bursa International Genetics Days: Dermatogenetics Symposium, Turkey, 9 - 10 January 2020, (Summary Text)

2019

49. Targeting complement in gut leakiness: A novel approach in protein-losing enteropathies.

ÖZEN A. O.

World Allergy Congress 2019, 12 - 14 December 2019, (Summary Text)

2019

50. Treatment of CHAPLE Syndrome Patients with Eculizumab.

ÖZEN A. O.

The first International Rumi Pediatric Conference 3rd J Project Congress., 4 - 07 December 2019, (Summary Text)

2019

51. Protein kaybettirici enteropatilerde kompleman aktivasyonu ve CD55 eksikliği oranının araştırılması

Selçuk M., AYDINER E., ÖĞÜLÜR İ., Tatlı İ., Kasap N., Kocamış B., et al.

XXVI. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 9 - 13 November 2019, (Summary Text)

2019

52. Ağır AD ve HIES ayrımında klinik ve laboratuvar belirteçlerin değerlendirilmesi

Kasap N., ÇELİK V., Işık S., Cennetoğlu P., KIYKIM A., NAİN E., et al.

26. Ulusal Allerji Ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 9 - 13 November 2019, pp.341, (Summary Text)

2019

53. Hiper IgE Sendromu ve Atopik Dermatit arasında dermatit dağılımı erken tanı için yararlı olabilir

Kasap N., ÇELİK V., Işık S., Cennetoğlu P., KIYKIM A., NAİN E., et al.

26. Ulusal Allerji Ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 9 - 13 November 2019, pp.30, (Summary Text)

2019

54. Phenotypic Analysis of Dermatitis Can Distinguish Hyper IgE Syndrome From Atopic Dermatitis

KASAP N., ÇELİK V., IŞIK S., CENNETOĞLU P., KIYKIM A., NAİN E., et al.

4th International Primary Immunodeficiencies Congress-IPIC 2019-Spain, 6 - 08 November 2019, (Summary Text)

2019

55. Clinical and Laboratory Markers Differentiate Hyper IgE Syndrome From Severe Atopic Dermatitis

KASAP N., ÇELİK V., CHARBONNIER L. M., IŞIK S., CENNETOĞLU P., KIYKIM A., et al.

4th International Primary Immunodeficiencies Congress-IPIC 2019-Spain, 6 - 08 November 2019, (Summary Text)

2019

56. Physicians’ Knowledge and Attitudes for IgG Replacement Therapy for Primary Immunodeficiency in Turkey

ÇELİK V., KASAP N., KOCAMIŞ B., BİLGİÇ ELTAN S., BARIŞ S., ÖZEN A. O., et al.

4th International Primary Immunodeficiencies Congress-IPIC 2019-Spain, 6 - 08 November 2019, (Summary Text)

2019

57. Patient’s Attitudes for Route of Immunoglobulin Replacement Therapy; Marmara Experience

KOCAMIŞ B., KASAP N., BİLGİÇ ELTAN S., BARIŞ S., ÖZEN A. O., KARAKOÇ AYDINER E.

4th International Primary Immunodeficiencies Congress-IPIC 2019-Spain, 6 - 08 November 2019, (Summary Text)

2019

58. Primer İmmün Yetmezlik hastaları ve sağlıklı bireylerde TREC/KREC kopya sayılarının analizi ve kullanımı: Pilot çalışma

Şentürk G., NG Y. Y., ERTAN S. B., YİLMAZ H., ÖĞÜLÜR İ., FIRTINA S., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 01 November 2019, (Summary Text)

2019

59. Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome

Labrosse R., Chu J., Armant M., van der Spek J., Miggelbrink A., Fong J., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text)

2019

60. Skin and Oral Provocation Tests in 29 Children with Clinical Reactivity to Betalactams; Marmara Experience

BİLGİÇ ELTAN S., KASAP N., KOCAMIŞ B., KIYKIM A., NAİN E., CAVKAYTAR Ö., et al.

6th Pediatric Allergy and Asthma Meeting (PAAM 2019)-Italy, 17 - 19 October 2019, (Summary Text)

2019

61. CHAPLE syndrome (CD55 deficiency with Hyperactivation of complement, Angiopathic thrombosis, and PLE): From discovery to translation into health.

ÖZEN A. O.

First Congress of Southeast European Pediatricians with International Participation., 4 - 06 October 2019, (Summary Text)

2019

62. Functional analysis of inflammation associated parameters in a case of NEMO deficiency before and after HSCT

Surucu N., KAYAOĞLU B., Geckin B., Ayanoglu I. C., Eltan S. B., Kasap N., et al.

17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS), Beijing, China, 19 - 23 October 2019, vol.49, pp.1232-1233, (Summary Text)

2019

63. Polymerase delta deficiency causes syndromic immunodeficiency with replicative stress

Conde D., Petronczki Ö., BARIŞ S., Willmann K., Girardi E., Salzer E., et al.

2nd European Society for Immunodeficiencies Focused Meeting, 18 - 21 September 2019, (Full Text)

2019

64. School board policies on prevention and management of anaphylaxis in Istanbul: Where do we stand?

Özen A. O., Boran P., Torlak F., Eltan B. S., Barış S., Karavuş M., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.908, (Summary Text)

2019

65. School board policies on prevention and management of anaphylaxis in Istanbul: Where do we stand?

ÖZEN A. O., BORAN P., TORLAK F., BİLGİÇ S., BARIŞ S., KARAVUŞ M., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), LİZBON, Portugal, 1 - 05 June 2019, vol.74, pp.908, (Summary Text)

2019

66. Characteristics of food allergy in children: National multicenter study

BİNGÖL A., Uygun K. D. F., AKDEMİR M., Erengin H., BOZDOGAN G., BINGOL G., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.503-504, (Summary Text)

2019

67. Schoolboard policies on prevention and management of anaphylaxis in Istanbul? Where do we stand?

ÖZEN A. O., BORAN P., torlak F., Eltan Bilgiç S., Baris S., KARAVUŞ M., et al.

EAACI 2019, 1 - 05 June 2019, (Full Text)

2019

68. IgE PRODUCTION IN CHRONIC GRANULOMATOUS DISEASE RELATED TO FUNGAL ANTIGENIC STIMULATION

ÖĞÜLÜR İ., AYDINER E., BARIŞ S., ÖZEN A. O., KIYKIM A.

MIMIC IV, 27 - 29 April 2019, (Full Text)

2019

69. Betalaktam Antibiyotiklerle Allerji Öyküsü Pozitif 29 Çocukta Deri Testlerinde Reaksiyon Oranı Sadece20

Bilgiç Eltan S., KASAP N., KOCAMIŞ B., KIYKIM A., NAİN E., CAVKAYTAR Ö., et al.

14. Uluslararası Katılımlı Çocuk Allerji ve Astım Kongresi, Antalya, Turkey, 22 - 25 April 2019, (Full Text)

2019

70. Geç Tip İlaç Reaksiyonu Olan Dört Olgunun Değerlendirilmesi; Marmara Deneyimi

KOCAMIŞ B., KASAP N., BİLGİÇ ELTAN S., YÜCELTEN A. D., ÖZEN A. O., KARAKOÇ AYDINER E., et al.

Uluslararası Katılımlı 14. Çocuk Alerji ve Astım Kongresi-Antalya, 22 - 25 April 2019, (Summary Text)

2019

71. Beta Laktam Antibiyotiklerle Allerji Öyküsü Pozitif 29 Çocukta Deri Testlerinde Reaksiyon Oranı Sadece %20

BİLGİÇ ELTAN S., KASAP N., KOCAMIŞ B., KIYKIM A., NAİN E., CAVKAYTAR Ö., et al.

Uluslararası Katılımlı 14. Çocuk Alerji ve Astım Kongresi-Antalya, 22 - 25 April 2019, (Summary Text)

2019

72. Allerji Öyküsü Olan Çocuklarda Aşı Uygulamaları; Tek Merkez Deneyimi

BARIŞ H. E., KIYKIM A., KASAP N., BİLGİÇ ELTAN S., KOCAMIŞ B., BORAN P., et al.

Uluslararası Katılımlı 14. Çocuk Alerji ve Astım Kongresi-Antalya, 22 - 25 April 2019, (Summary Text)

2019

73. Kronik granülomatöz hastalıkta akan hücre ölçerde belirlenen NADPH oksidaz alt ünitelerinin genotipi öngermede rolü

BARIŞ H. E., ÖĞÜLÜR İ., AKCAM B., KIYKIM A., BİLGİÇ ELTAN S., KÖKER M. Y., et al.

6. Marmara Pediatri Kongresi, İstanbul, Turkey, 21 - 23 February 2019, (Summary Text)

2018

74. Genomics Research Uncovers the Primary Role of Complement Pathway in a Familial Form of Protein Losing Enteropathy

ÖZEN A. O.

Functional Genomics 2018, 8 - 10 December 2018, (Full Text)

2018

75. Immunisation practices in children with a history of allergies

Barış H. E., BORAN P., KIYKIM A., BARIŞ S., ÖZEN A. O., AYDINER E.

1st International Eurasian Congress of Social Pediatrics, 01 December 2018, (Full Text)

2018

76. çocuklArDA besin Allerjisinin kArAkteristik özellikleri: ulusAl çok merkezli çAlışmA

BİNGÖL A., KOCACIK UYGUN D. F., AKDEMİR M., ERENGİN K. H., BOZDOĞAN G., BİNGÖL G., et al.

XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, (Summary Text)

2018

77. Kronik Granülomatöz Hastalıkta Akan Hücre Ölçerde Belirlenen NADPH Oksidaz Enzim Aktivitesinin ve Alt Ünitelerinin Genotipi Öngörmede Rolü

Akçam B., Barış E., ÖĞÜLÜR İ., Kasap N., Bilgiç Eltan S., Başer D., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Derneği, Antalya, Turkey, 17 - 21 November 2018, (Full Text)

2018

78. BCG Aşısına Bağlı Komplikasyon Gelişen Bir Olguda Saptanan İnterlökin 12-23/İnterferon Gamma Yolağında Bozukluk

TÜREL Ö., AKKOÇ G., KASAP N., BURSAL DURAMAZ B., KIRMACI Ç., ÖZEN A. O., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 17 - 21 November 2018, (Summary Text)

2018

79. CHAPLE Hastalığında Eritro-Lökosit Agregasyonu Belirteç Olarak Kullanılabilir Mi?

Akgün G., Başer D., AYDINER E., ÖĞÜLÜR İ., Kasap N., Bilgiç Eltan S., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, (Full Text)

2018

80. Ataksi Telenjiektazi Hastalarının Ebeveynlerinde Enfeksiyonlar ve Lenfosit Alt Grup Bozuklukları

ÖĞÜLÜR İ., Ertüzün T., ÖZEN A. O., UYAR E., KIYKIM A., Başer D., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, (Full Text)

2018

81. Dihidrorhodamin Testinde Yanlış Pozitiflik ile Tanınan Bir MPO Eksikliği Olgusu

Başer D., BARIŞ S., Türe Özdemir F., ÖĞÜLÜR İ., Kasap N., Bilgiç Eltan S., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, (Summary Text)

2018

82. CHAPLE Hastalığında Eritro-Lökosit Agregasyonu Biyobelirteç Olarak Kullanılabilir Mi?

AKGÜN G., BAŞER D., KARAKOÇ AYDINER E., ÖĞÜLÜR İ., KASAP N., ELTAN S., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 17 - 21 November 2018, (Summary Text)

2018

83. Tedaviye Dirençli Sistemik Otoinflamatuar Bulgularla Seyreden NEMO Eksikliği Olgusu

BİLGİÇ ELTAN S., SÜRÜCÜ N., KASAP N., KIYKIM A., NAİN E., YÜCELTEN A. D., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 17 - 21 November 2018, (Summary Text)

2018

84. Lupus Benzeri Cilt Bulguları ve Lenfoproliferasyon ile Seyreden IL-21 Reseptör Eksikliği Olgusu

KASAP N., BİLGİÇ ELTAN S., KIYKIM A., SOMER A., BOZTUĞ K., ÖZEN A. O., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 17 - 21 November 2018, (Summary Text)

2018

85. DOCK8 Benzeri Bulgularla Ortaya Çıkan Biallelik CARMIL2 (RTLPR) Mutasyonu

KASAP N., AYDINER E., NAİN E., KIYKIM A., CHARBONNIER L. M., BİLGİÇ ELTAN S., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 17 - 21 November 2018, (Summary Text)

2018

86. Akan Hücre ile CD55 Eksikliği Hastalığı Taraması

ÖĞÜLÜR İ., SARI S., KIYKIM A., Akgün G., NAİN E., TUTAR E., et al.

XXV. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, (Full Text)

2018

87. IMMUNOPHENOTYPING DIFFERENCES IN HYPER-IGE SYNDROMES ASSOCIATED WITH DOCK8 AND STAT3 MUTATIONS?

Başer D., ÖĞÜLÜR İ., KIYKIM A., Kasap N., NAİN E., BARIŞ S., et al.

18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

88. CD55 MEDIATED LOSS OF CO-STIMULATION CAUSES INSUFFICIENT IL10 PRODUCTION IN PATIENTS WITH CD55

ÖZEN A. O., ÖĞÜLÜR İ., KIYKIM A., BARIŞ S., AYDINER E.

18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

89. MOTHERS OF AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS DISEASE PATIENTS DO NOT SHOW AUTOIMMUNE FINDINGS IN CONTRAST TO X-LINKED PATIENTS

Barış E., KIYKIM A., NAİN E., Aksoy G., ÖĞÜLÜR İ., Başer D., et al.

18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

90. POTENTIAL ROLE OF NATURAL KILLER CELLS IN LRBA DEFICIENCY

ÇINAR S., GELMEZ M. Y., AKDENİZ N., Ozcit G., KIYKIM A., ÖZEN A. O., et al.

18th ESID, 24 - 27 October 2018

2018

91. A FLOW-CYTOMETRY BASED SCREENING FOR CD55 DEFICIENCY IS A RAPID

ÖĞÜLÜR İ., SARI S., KIYKIM A., NAİN E., TUTAR E., AYDINER E., et al.

The 18th Biennial Meeting of ESID, LİZBON, Portugal, 24 - 27 October 2018, (Summary Text)

2018

92. A FLOW-CYTOMETRY BASED SCREENING FOR CD55 DEFICIENCY IS A RAPID

ÖĞÜLÜR İ., SARI S., KIYKIM A., NAİN E., TUTAR E., AYDINER E., et al.

18TH BIENNIAL MEETING OF THE EUROPEAN SOCIETY FOR IMMUNODEFICIENCIES (ESID) 2018, 24 - 27 October 2018, (Summary Text)

2018

93. A TURKISH LRBA DEFICIENCY COHORT PROVIDING CLINICAL AND LABORATORYUTILITIES

KIYKIM A., DURSUN E., NAİN E., ÇEKİÇ Ş., ÖĞÜLÜR İ., BAŞER D., et al.

The 18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

94. INFECTIONS AND LYMPHOCYTE SUBSET ALTERATIONS IN ATAXIA TELANGIECTASIA MUTATED KINASE CARRIERS

ÖĞÜLÜR İ., Ertüzün T., ÖZEN A. O., UYAR E., KIYKIM A., Başer D., et al.

18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

95. INTRACELLULAR STAINING OF SUBUNITS OF NADPH OXIDASE ENZYME PREDICTS DEFECTIVE GENE IN PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE

Barış E., ÖĞÜLÜR İ., Akçam B., Başer D., KIYKIM A., Kasap N., et al.

18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

96. IS IT POSSIBLE TO DISTINGUISH TRUE LRBA PATIENTS WITH THE EXPRESSION OF THE LRBA PROTEIN BY FLOW CYTOMETER?

ÖĞÜLÜR İ., KIYKIM A., AYDINER E., BARIŞ S., ÖZEN A. O.

18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

2018

97. LRBA eksikliğinde CTLA-4 analoğunun (abatacept) lenfosit alt tipleri üzerine ex-vivo etkileri

KIYKIM A., ÖĞÜLÜR İ., Dursun E., YILDIRAN A., UNCUOĞLU A., KELEŞ S., et al.

İmmünolojide Moleküller Sempozyumu, İzmir, Turkey, 18 - 21 October 2018, (Summary Text)

2018

98. Early onset protein losing enteropathy and thrombosis in inherited CD55 deficiency

ÖZEN A. O.

5th European Congress of Immunology, 3 - 06 September 2018, (Full Text)

2018

99. Evaluation of a standardized bakery product (SUTMEK) as a potential tool for baked milk tolerance and immunotherapy research studies

Kiykim A., Karakoc-Aydiner E., Gunes E., Nain E., ÖĞÜLÜR İ., AKTAÇ Ş., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Germany, 26 - 30 May 2018, vol.73, pp.122-123, (Summary Text)

2018

100. Evaluation of a standardized bakery product (SUTMEK) as a potential tool for baked milk tolerance and immunotherapy research studies

KIYKIM A., AYDINER E., GÜNEŞ F. E., NAİN E., ÖĞÜLÜR İ., AKTAÇ Ş., et al.

European Academy of Allergy and Clinical ImmunologyCongress, Munich, Germany, 26 - 30 May 2018, vol.73, (Summary Text)

2018

101. The effect of high dose vitamin‐D onlymphocytes in children with atopic dermatitis

ÖĞÜLÜR İ., ÖZEN A. O., NAİN E., KIYKIM A., BARIŞ S., AYDINER E.

European Academy of Allergy and Clinical ImmunologyCongress, 26 - 30 May 2018, vol.73, (Summary Text)

2018

102. SOTI in IgE mediated cow's milk allergy, two case reports

Kasap N., Kiykim A., Karakoc-Aydiner E., Ozen A. O., Baris S.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Germany, 26 - 30 May 2018, vol.73, pp.842, (Summary Text)

2018

103. Functional reprogramming of regulatory T cells in the absence of Foxp3

Charbonnier L., David L., Bleesing J., GarciaLloret M., Chen K., ÖZEN A. O., et al.

Immunology 2018™ Meeting, Turkey, 9 - 11 May 2018, (Full Text)

2018

104. A Novel Mendelian Disease of Autoimmunity caused by Mutations in a small GTPase

LeneyGreene M. A., Park A., Chao B., Vilarinho S., Su H., ÖZEN A. O., et al.

Immunology 2018™ Meeting, Turkey, 04 June 2018, (Full Text)

2018

105. Group 3 innate lymhoid cells are absent in DOCK8-defective HIES patients

EKEN A., Okus F. Z., Patiroglu T., Erdem S., KARAKÜKCÜ M., Cansever M., et al.

Annual Meeting of the American-Association-of-Immunologists (AAI), Texas, United States Of America, 4 - 08 May 2018, vol.200, (Summary Text)

2018

106. LRBA Eksikliğini Diğer İmmün Yetmezliklerden Farklı Kılan Klinik ve Laboratuvar Özellikler

KIYKIM A., DURSUN E., NAİN E., ESER ŞİMŞEK I., ÇÖĞÜRLÜ M. T., BAŞER D., et al.

4. Uluslararası Katılımlı Klınık Immünolojı Kongresı, Antalya, Turkey, 11 - 14 April 2018, (Summary Text)

2018

107. “Çıplak” Ağır Kombine İmmün Yetmezlikli 2 Kardeşte Tanımlanan Yeni Foxn1 Mutasyonu

FIRTINA S., ÇİPE F., KIYKIM A., HATIRNAZ N. Ö., SUDUTAN T., AYDOĞMUŞ Ç., et al.

4. Klinik İmmünoloji Kongresi, Turkey, 11 - 14 April 2018, (Summary Text)

2018

108. Detection of T-cell Receptor Excision Circles (TRECs) in Dried Blood Spot (DBS) Implementation of Routine Newborn Screening For The Diagnosis of SCID,

NG Y. Y., FIRTINA S., HATIRNAZ N. Ö., KIYKIM A., AYDINER E., ÖZEN A. O., et al.

4. Klinik İmmünoloji Kongresi, Turkey, 11 - 14 April 2018, (Summary Text)

2018

109. LRBA Eksikliğini Diğer İmmün Yetmezliklerden Farklı Kılan Klinik ve Laboratuvar Özellikler

KIYKIM A., DURSUN E., NAİN E., ESER ŞİMŞEK I., ÇEKİÇ Ş., ÇÖĞÜRLÜ M. T., et al.

Uluslararası Katılımlı 4. Klinik İmmünoloji Kongresi-Antalya, 11 - 14 April 2018, (Summary Text)

2018

110. Kronik Granülomatöz Hastalıkta Pioglitazone Tedavisi İşe Yarıyor Mu?

KASAP N., KIYKIM A., KARAKOÇ AYDINER E., ÖZEN A. O., BARIŞ S.

Uluslararası Katılımlı 4. Klinik İmmünoloji Kongresi-Antalya, 11 - 14 April 2018, (Summary Text)

2018

111. Hiper IgE hastalarında genişlenfosit alt-tiplendirme DOCK8 ve STAT3 ayrımını gösteren belirteç nedir?

Başer D., ÖĞÜLÜR İ., KIYKIM A., Kasap N., NAİN E., BARIŞ S., et al.

4. Klinik İmmünoloji Kongresi, Antalya, Turkey, 11 - 14 April 2018, (Summary Text)

2018

112. Primer İmmun Yetmezlik Tanılı Hastalarda Malignite Çeşitliliği

KIYKIM A., SÜREKLİ Ö., NAİN E., KASAP N., AKTÜRK H., DOĞRU Ö., et al.

4. Uluslararası Katılımlı Klinik İmmünoloji Kongresi-Antalya, 11 - 14 April 2018, (Summary Text)

2018

113. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy and Trombosis

Özen A. O., Comrıe A., Ardy R., Conde D., Dalgıç B., Beşer Ö. F., et al.

World Immune Regulation Meeting XII, Dubendorf, Switzerland, 14 - 17 March 2018, (Summary Text)

2018

114. STAT1 gain-of-function the immune disregulated mechanisms behind the disease

BARIŞ S., ÖĞÜLÜR İ., CHARBONNIER L. M., ALROQI F., KIYKIM A., AYDINER E., et al.

World Immune Regulation Meeting XII, Davos, Switzerland, 14 - 17 March 2018, (Summary Text)

2018

115. Absence of group 3 innate Iymphoid cells in DOCK8- defective HIES patients

EKEN A., PATIROĞLU T., Okuş F. Z., erdem ş., Karakükçü m., CANSEVER M., et al.

The World Immune Regulation Meeting XII (WIRM XII) kongresi, 14 - 17 March 2018, (Summary Text)

2018

116. CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis

ÖZEN A. O.

12th World Immune Regulation Meeting (WIRM), 15 - 17 March 2018, (Full Text)

2017

117. Akan hücre ölçerde LRBA protein ifadesi tayini ile gerçek LRBA hastaları ayırt edilebilir mi?

ÖĞÜLÜR İ., KIYKIM A., AYDINER E., BARIŞ S., ÖZEN A. O.

XXIV. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 18 - 21 November 2017, (Summary Text)

2017

118. IgE Aracılı İnek Sütü Protein Allerjisinde SOTİ; İki Olgu Sunumu

KASAP N., KIYKIM A., KARAKOÇ AYDINER E., ÖZEN A. O., BARIŞ S.

XXIV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 18 - 22 November 2017, (Summary Text)

2017

119. ADA Eksikliğine Bağlı AKİY’de Erken Tanı ve Tedavinin Önemi, Olgu Sunumu

KASAP N., KIYKIM A., YILMAZ N. B., BARIŞ S., KARAKOÇ AYDINER E., ÖZEN A. O.

XXIV. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Antalya, 18 - 22 November 2017, (Summary Text)

2017

120. Hypomorfic JAK3 and IL2RG Mutations Presenting with a Predominantly Antibody DEficiency Phenotype

KIYKIM A., FIRTINA S., ye z., ee n., SAYİTOĞLU M., BARIŞ S., et al.

European Society for Immunodeficiencies (ESID) Meeting, 11 - 14 November 2017, (Summary Text)

2017

121. Molecular Dıagnosıs Of Scıd Patıents By A Custom Desıgned Targeted Next Generatıon Sequencıng Panel

FIRTINA S., SAYİTOĞLU M., HATIRNAZ N. Ö., KIYKIM A., AYDINER E., BARIŞ S., et al.

International Primary Immunodeficiencies Congress, 8 - 10 November 2017, (Summary Text)

2017

122. MOLECULAR DIAGNOSIS OF SCID PATIENTS BY A CUSTOM DESIGNED TARGETED NEXT GENERATION SEQUENCING PANEL

FIRTINA S., SAYİTOĞLU M., NG HATIRNAZ O., KIYKIM A., AYDINER E., BARIŞ S., et al.

ınternational Primary Immunodeficiencies Congress 2017, 8 - 10 November 2017, (Summary Text)

2017

123. Molecular Diagnosis of SCID Patients by a custom designed targeted next generation sequencing panel

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Barış S., et al.

IPIC 2017, 8 - 10 November 2017, (Summary Text)

2017

124. The effect of in vitro high dose vitamin-D on lymphocytes in children with atopic dermatitis

ÖĞÜLÜR İ., ÖZEN A. O., NAİN E., KIYKIM A., BARIŞ S., AYDINER E.

PAAM 2017, 26 - 28 October 2017, (Summary Text)

2017

125. The applicability of our product to evaluate the baked milk tolerance in cow’s milk allergic children

KIYKIM A., ÖZEN A. O., GÜNEŞ F. E., NAİN E., ÖĞÜLÜR İ., AKTAÇ Ş., et al.

PAAM 2017, 26 - 28 October 2017, (Full Text)

2017

126. Reference values for lymphocyte subsets in healthy children and adolescent JMF Marmara Center

BESCİ Ö., ÖĞÜLÜR İ., ÇİÇEKKÖKÜ D., KIYKIM A., NAİN E., BORAN P., et al.

18th Biennial Meeting of ESID 2017, 11 - 14 October 2017, (Summary Text)

2017

127. Rapid SCIG infusion in primary immune deficiency patients: Marmara experience

Kıkyım A., Ercan N., ÖZEN A. O., Barış S., AYDINER E.

IPIC 2017, 8 - 10 October 2017, (Summary Text)

2017

128. Adverse Reactions to IVIG in primary immune deficiency patients: MArmara experience

Kıykım A., Nain E., ÖZEN A. O., Barış S., AYDINER E.

IPIC 2017, 8 - 10 October 2017, (Summary Text)

2017

129. Molecular Diagnosis of SCID patients by a custom designated targeted next generation sequencing panel

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Baris S., et al.

IPIC 2017, 8 - 10 October 2017, (Summary Text)

2017

130. CCNO mutasyonlu primer silyer diskinezili hastalarda genetik tanının önemi

ERGENEKON A. P., BATU U., BAŞ İKİZOĞLU N., ATAĞ E., GÖKDEMİR Y., ERDEM ERALP E., et al.

2. Çocuk Göğüs Hastalıkları Kongresi, Turkey, 27 - 29 September 2017

2017

131. Hematopoietic stem cell transplantation in patients with heterozygous STAT1 gain of function mutation.

Kıykım A., Charbonnier L., AKÇAY A., Ercan N., AYDINER E., ÖZEN A. O., et al.

ESID 2017, 11 - 14 September 2017, (Summary Text)

2017

132. Immunodeficiency caused by activating mutations in the subunits of PI3K and treatment with sirolimus

KIYKIM A., AYDINER E., ÖĞÜLÜR İ., NAİN E., BARIŞ S., ÖZEN A. O.

18th Biennial Meeting of ESID 2017, 11 - 14 September 2017, (Summary Text)

2017

133. Hypomorphic JAK3 and IL2RG mutations presenting with a predominanty antibody deciency phenotype

Kıykım A., Fırtına S., zhang Y., Ercan N., SAYİTOĞLU M., Baris S., et al.

ESID 2017, 11 - 14 September 2017, (Summary Text)

2017

134. Inherited CD55 deficiency in patients with early onset protein-losing enteropathy and thrombosis

Özen A. O., Dalgıç B., Beşer Ö. F., Ardy R. C., Tutar E., Barış S., et al.

The 50th Annual Meeting of The European Society of Paediatric Gastroenterology, Hepatology and Nutrition, Praha, Czech Republic, 10 - 13 May 2017, vol.64, no.1, pp.1-1017, (Summary Text)

2017

135. A Novel Mendelian Disease of Autoirnrnunity caused by Mutations in a small GTPase

Greene A., Park A., Chao B., Schwefel D., ÖZEN A. O., Morawski A., et al.

Immunology Meeting, 12 - 16 May 2017, (Full Text)

2017

136. Kalıtsal İnsan CD55 Eksikliği Hastalığı Modelinde T Hücre Eş-uyarımı ve CD55 Sinyalizasyonu

ÖZEN A. O., ÖĞÜLÜR İ., KIYKIM A., BARIŞ S., AYDINER E.

XXIV. Ulusal İmmünoloji Kongresi, İstanbul, Turkey, 27 - 30 April 2017, (Summary Text)

2017

137. Erişkin Yaşta Tanı Alan X’e Bağlı Hipomorfik İmmün Yetmezlik

KIYKIM A., FIRTINA S., NAİM E., BARIŞ S., SAYİTOĞLU M., AYDINER E., et al.

3. Klinik İmmünoloji Kongresi, Turkey, 12 - 15 April 2017, (Summary Text)

2017

138. Erişkin Yaşta Tanı Alan X’xxe bağlı Hipomorfik İmmün Yetmezlik

Kıykım A., Fırtına S., Naim E., Barış S., SAYİTOĞLU M., AYDINER E., et al.

3. Klinik İmmünoloji Kongresi, Turkey, 12 - 15 April 2017, (Summary Text)

2017

139. Inherited CD55 deficiency in patients with early onset protein-losing enteropathy and thrombosis

Özen A. O., Comrıe W., Ardy R., Conde C., Dalgic B., Beser O. F., et al.

50th Annual Meeting of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition, Praha, Czech Republic, 10 - 13 May 2017, vol.64, no.1, pp.40, (Full Text)

2016

140. Süt alerjili çocuklarda fırınlanmış sütün tüketilebilirliğini test etmek için geliştirdiğimiz ürünün kullanımı

kıykım a., GÜNEŞ F. E., nain e., ÖĞÜLÜR İ., AKTAÇ Ş., biçer a. h., et al.

XXIII. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Turkey, 8 - 12 October 2016

2016

141. Hiper IgM Sendromu Nadir Formu; AICDA Gen Mutasyonu

ARUÇİ KASAP N., KIYKIM A., NAİN E., ÖZEN A. O., KARAKOÇ AYDINER E., BARIŞ S.

XXIII. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Bodrum, 8 - 12 October 2016, (Summary Text)

2016

142. Süt Alerjili Çocuklarda Fırınlanmış Sütün Tüketilebilirliğini Test Etmek için Geliştirdiğimiz Ürünün Kullanımı

KIYKIM A., GÜNEŞ F. E., NAİN E., ÖĞÜLÜR İ., AKTAÇ Ş., BİÇER A. H., et al.

KONGRE, Turkey, 8 - 12 October 2016, (Summary Text)

2016

143. Subkutan İmmünoglobulin Tedavisinde Hızlı İnfüzyon Yöntemi; Marmara Deneyimi

KIYKIM A., NAİN E., ARUÇİ KASAP N., BAKIR M., ÖZEN A. O., BARIŞ S., et al.

XXIII. Ulusal Allerji ve Klinik İmmünoloji Kongresi-Bodrum, 8 - 12 October 2016, (Summary Text)

2016

144. Evaluation of DOCK8 Deficienct Patients A single Center Experience From Turkey

Kıykım A., AYDINER E., ÖĞÜLÜR İ., Barış S., NAİN E., ŞAH O., et al.

ESID 2016 Biannual Meeting, 21 - 24 September 2016, (Summary Text)

2016

145. Early onset protein losing enteropathy bowel inflammation and thrombosis in patients with complement regulator deficiency

Ardy R., Özen A. O., Comrie W., Dominguez C., Dalgıç B., Beşer Ö., et al.

ESID 2016 Biennial Meeting, Barcelona, Spain, 21 - 24 September 2016, (Full Text)

2016

146. Is there immunodeficiency in heterozygous carrier for ataxia telengiectasia

ÖĞÜLÜR İ., Barış S., ÖZEN A. O., UYAR E., Kıykım a., Çiçekkökü D., et al.

ESID 2016 Biennial Meeting, 21 - 24 September 2016, (Summary Text)

2016

147. Diagnostic Flow Cytometry And Treatment Experience in LRBA Deficiency 4 patients from Marmara

ÖĞÜLÜR İ., Kıykım A., AYDINER E., Barış S., ÖZEN A. O., NAİN E., et al.

ESID 2016 Biennial Meeting, 21 - 24 September 2016, (Summary Text)

2016

148. Neurocogitive Impairment In Ataxia Telengiectasia PAtients and Their Parents

UYAR E., AKTÜRK H., Usanmaz S., Kıykım A., Omer A., ÖZEN A. O., et al.

ESID 2016 Biennial Meeting, 21 - 24 September 2016, (Summary Text)

2016

149. Evaluation of DOCK8 deficient patients A single center experience from Turkey

Kıykım A., AYDINER E., ÖĞÜLÜR İ., Barış S., NAİN E., ŞAH O., et al.

2016 ESID Biennal meeting, 21 - 24 September 2016, (Summary Text)

2016

150. Neurocognitive Impairement in Ataxia Telangiectasia Patients and Their Parents

UYAR E., AKTÜRK H., Usanmaz S., Kıykım A., Aydıner Ö., Somer A., et al.

2916 ESID Biennal Meeeting, 21 - 24 September 2016, (Summary Text)

2016

151. Lymphocyte subsets in pediatric common variable immune deficiencies with organ involvement

ÖĞÜLÜR İ., AYDINER E., ÖZEN A. O., kıykım a., NAİN E., çiçekkökü D., et al.

2016 ESID Biennal Meeting, 21 September 2016, (Summary Text)

2016

152. Is there immunodeficiency in heterozygous carrier for ataxia telangiectasia

ÖĞÜLÜR İ., Barış S., ÖZEN A. O., UYAR E., Kıykım A., Çiçekköükü D., et al.

2016 ESID Biennal Meeting, 21 - 24 September 2016, (Summary Text)

2016

153. Basophil activation test is reliable for inhalant allergens in pediatric patients

ÖĞÜLÜR İ., Kıykım A., Barış S., ÖZEN A. O., Onat E. G., Bakır M., et al.

3rd International Molecular Immunology & Immunogenetics Congress, 27 - 30 April 2016, (Summary Text)

2016

154. Intracellular staining of DOCK8 LRBA SAP and XIAP proteins by flow cyttometry Marmara Experience

ÖĞÜLÜR İ., barış S., ÖZEN A. O., Kıykım A., Bakır M., AYDINER E., et al.

3rd International Molecular Immunology & Immunogenetics Congress, 27 - 30 April 2016, (Summary Text)

2016

155. Intracellular staining of DOCK8 LRBA SAP and XIAP proteins by flow cytometry Marmara experience

ÖĞÜLÜR İ., Barış S., ÖZEN A. O., Kıykım A., bakır M., AYDINER E., et al.

3rd International Molecular Immunology & Immunogenetics Congress (MIMIC-III), 27 - 30 April 2016, (Summary Text)

2016

156. Monogenic Primary Immune Deficiencies Identified In a Pediatric Onset CVID Cohort Is there a predictive Marker

AYDINER E., Kiykim A., NAİN E., Kaçmaz M., ÖĞÜLÜR İ., Barış S., et al.

2016 CIS Annual Meeting: Immune Deficiency & Dyregulation North American Conference, 14 - 17 April 2016, (Summary Text)

2016

157. A PATIENT WITH A MUTATION IN CD40L PRESENTING WITH PANHYPOGAMMAGLOBULINEMIA AND NATURAL KILLER CELL LYMPHOPENIA

Safa B., AYDINER E., Kıykım A., NAİN E., ÖZEN A. O., bachiloğlu r., et al.

2016 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference, 14 - 17 April 2016, (Summary Text)

2016

158. DO CUT OFF VALUES OF IgE AND EOSINOPHIL LEVELS HELP DISCRIMINATE HYPERIGE SYNDROME FROM ATOPIC DISEASES

AYDINER E., Kiykim A., Yuce E., Barış E., NAİN E., KELEŞ S., et al.

2016 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference, 14 - 17 April 2016, (Summary Text)

2016

159. A patient with a mutation in CD40L presenting with panhypogammaglobulinemia and natural killer lymphopenias

Barış S., AYDINER E., kıykım a., NAİN E., ÖZEN A. O., hoyosbachioglu r., et al.

2016 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference, 14 - 17 April 2016, (Summary Text)

2016

160. MONOGENIC PRIMARY IMMUNE DEFICIENCIES IDENDIFIED IN A PEDIATRIC-ONSET CVID COHORT, IS THERE A PREDICTIVE MARKER?

Karakoc-Aydiner E., Kiykim A., Nain E., Kacmaz M., Ogulur I., BARIŞ S., et al.

CIS Annual Meeting on Immune Deficiency and Dysregulation North American Conference, Massachusetts, United States Of America, 14 - 17 April 2016, vol.36, pp.253-254, (Summary Text)

2016

161. DO CUT-OFF VALUES OF IgE AND EOSINOPHIL LEVELS HELP DISCRIMINATE HYPERIGE SYNDROME FROM ATOPIC DISEASES?

Karakoc-Aydiner E., Kiykim A., Yuce E. G., Baris E., Nain E., Keles S., et al.

CIS Annual Meeting on Immune Deficiency and Dysregulation North American Conference, Massachusetts, United States Of America, 14 - 17 April 2016, vol.36, pp.254, (Summary Text)

2016

162. A PATIENT WITH A MUTATION IN CD40L PRESENTING WITH PANHYPOGAMMAGLOBULINEMIA AND NATURAL KILLER CELL LYMPHOPENIA

BARIŞ S., Karakoc-Aydiner E., Kiykim A., Nain E., Ozen A. O., Hoyos-Bachiloglu R., et al.

CIS Annual Meeting on Immune Deficiency and Dysregulation North American Conference, Massachusetts, United States Of America, 14 - 17 April 2016, vol.36, pp.311, (Summary Text)

2016

163. Ataksi Telenjiektazi heterozigot taşıyıcılarda immün yetmezlik var mı

ÖĞÜLÜR İ., AYDINER E., Barış S., ÖZEN A. O., UYAR E., kıykım a., et al.

3. Marmara Pediatri Kongresi, Turkey, 18 - 20 February 2016

2015

164. Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome

CHU J., Henderson L., Armant M., Male F., Dansereau C., MacKinnon B., et al.

57th Annual Meeting of the American-Society-of-Hematology, 5 - 08 December 2015

2015

165. Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome

Julia I., JH H., Armant M., Francis M., Danceraneu C., Brenda M. K., et al.

ASH 57th Annual Meeting and Exposition, 5 - 08 December 2015, (Full Text)

2015

166. Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome

Chu J. I., Henderson L. A., Armant M., Male F., Dansereau C. H., MacKinnon B., et al.

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)

2015

167. Atopik hastalıklar ile immün yetmezlikleri ayırmada serum Ig E ve eozinofil kesim değerleri nedir

Ayça K., AYDINER E., Yüce E., Hatice Ezgi B., NAİN E., KELEŞ S., et al.

XXII AİD Kongresi, Turkey, 27 November - 01 December 2015, (Full Text)

2015

168. Çocukluk çağı zor astım tanısında nadir bir hastalık Omuz kuşak miyopatisi

NAİN E., Ayça K., Reha C., ÖZEN A. O., Safa B., AYDINER E., et al.

XXII AİD Kongresi, Turkey, 27 November - 01 December 2015, (Summary Text)

2015

169. Allerjenle indüklenmiş Bazofil aktivasyonu ileIgE aracılı yanıtın in vitro gösterimi

ÖĞÜLÜR İ., Yüce E., Ayça K., Barış S., ÖZEN A. O., AYDINER E., et al.

XXII AID Kongresi, Turkey, 27 November - 01 December 2015, (Summary Text)

2015

170. Ev tozu akarı duyarlı atopic dermetit tanılı hastaların demografik ve klinik özellikleri

NAİN E., Ayça K., Cemre Y., Bayramlı R., Barış S., ÖZEN A. O., et al.

XXII AİD Kongresi, Turkey, 27 November - 01 December 2015, (Summary Text)

2015

171. Ev tozu akarına duyarlı astım ve veya rinitli çocuklarda sublingual immünotearpinin ağız ve diş sağlığı üzerine etkisi

Ayça K., ÖĞÜLÜR İ., Safa B., AYDINER E., ÖZEN A. O., BAKIR M., et al.

XXII AİD Kongresi, Turkey, 27 November - 01 December 2015, (Summary Text)

2015

172. Çoklu aeroallerjen duyarlı astın ve/veya rinitli çocuklarda semptomlardan sorumlu ana allerjeni öngörmede provokasyon testi şart mıdır?

Yüce E. G., ÖĞÜLÜR İ., BARIŞ S., KIYKIM A., ŞAHİN YILMAZ A. A., OYSU Ç., et al.

XXII. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 28 November - 02 December 2015, vol.13, pp.12, (Summary Text)

2015

173. SCIG for PID patients single center Marmara experience

AYDINER E., Ayça K., Safa B., NAİN E., ÖZEN A. O., Işıl B.

IPIC, 5 - 06 November 2015, (Summary Text)

2015

174. Konjenital nötropeni ile ilişkili ELANE ve HAX1 gen mutasyonlarının Türk toplumunda sıklıklarının araştırılmas

Mercan S., Bilge Ö., Çağrı G., KARAMAN S., AYDOĞDU S., Ayça K., et al.

41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015, (Summary Text)

2015

175. Lymphocyte subsets in healthy adult individuals determination of reference values

ÖĞÜLÜR İ., Başer D., BARIŞ S., AYDINER E., ÖZEN A. O., BARLAN I.

4th European Congress of Immunology, Viyana, Austria, 6 - 09 September 2015, (Summary Text)

2015

176. Purine nucleoside phosphorylase (PNP) deficiency presenting as combined immune deficiency with no infections

Kiykim A., Kiykim E., Karakoc-Aydiner E., Nain E., Baris S., Ozen A. O., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.449, (Summary Text)

2015

177. Purine nucleoside phosphorylase PNP deficiency presenting as combined immune deficiency with no infections

kiykim a., kiykim e., karakoc aydiner e., NAİN E., baris S., ÖZEN A. O., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 - 10 June 2015

2015

178. Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: a double-blind, double-dummy study

Demirca P. B., Cagan H. H., Kiykim A., Arig U., Arpa M., Tulunay A., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.347, (Summary Text)

2015

179. To estimate the major allergen in multi-sensitized children with rhinitis: is nasal provocation really needed?

Yuce E. G., Ogulur I., Karakoc-Aydiner E., Baris S., Kiykim A., Yilmaz S. A., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.119, (Summary Text)

2015

180. The effect of systemic corticosteroids on the innate and adaptive immune system

Baris H. E., Baris S., Karakoc-Aydiner E., Ogulur I., Cicekkoku D., Yigit O., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.437, (Summary Text)

2015

181. Is there any marker to predict target organ involvement in combined immunodeficient patients?

Ogulur I., Karakoc-Aydiner E., Baris S., Kiykim A., Nain E., Ozen A. O., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.371, (Summary Text)

2015

182. Nebulized fluticasone propionate a viable alternative to systemic route in the management of childhood moderate asthma attack a double blind double dummy study

demirca B., cagan h., kiykim a., arig u., arpa m., tulunay a., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 06 June 2015

2015

183. Lymphocyte subset abnormalities in heterozygous carrier state for ataxia telangiectasia

ogulur i., baris S., aydiner karakoc e., uyar e., kiykim a., cicekkoku d., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 - 10 June 2015

2015

184. Is there any marker to predict target organ involvement in combined immunodeficient patients

ogulur i., karakoc aydiner e., baris S., kiykim a., NAİN E., ÖZEN A. O., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 - 10 June 2015

2015

185. To estimate the major allergen in multi sensitized children with rhinitis is nasal provocation really needed

Yüce E., ÖĞÜLÜR İ., AYDINER E., Safa B., Kıykım a., Yılmaz a., et al.

XXXIV Congress of European Academy of Allergy and Clinical Immunology konferansı, 6 - 10 June 2015, (Full Text)

2015

186. The effect of allergen avoidance on asthma control in house dust mite sensitized asthmatic children

YÜCE E. G., ÖĞÜLÜR İ., AYDINER E., BARIŞ S., KIYKIM A., ŞAHİN YILMAZ A., et al.

XXXXIV Congress of European Academy of Allergy and Clinical Immunology, Barcelona, Spain, 6 - 10 June 2015, (Full Text)

2015

187. To estimate the major allergen in multi sensitized children with rhinitis is nasal provocation really needed 1497 nolu Barselona İspanya

EG Y., ÖĞÜLÜR İ., AYDINER E., Safa B., Ayça K., Aslı Ş. Y., et al.

XXXIV Congress of European Academy of Allergy and Clinical Immunology, 6 - 09 June 2015, (Full Text)

2015

188. Fagositlerde dihidrorodamin ile oksidatif patlama sağlıklı bireylerde normatif veriler

Diilek Ç., ÖĞÜLÜR İ., AYDINER E., Safa B., ÖZEN A. O., Işıl B.

23. Ulusal İmmünoloji Kongresi, Turkey, 26 - 30 April 2015, (Full Text)

2015

189. Fagositlerde dihidrorhodamin ile oksidatif patlama; sağlıklı bireylerde normatif veriler

Çiçekkökü D., ÖĞÜLÜR İ., AYDINER E., BARIŞ S., ÖZEN A. O., BARLAN I.

23. Ulusal İmmünoloji Kongresi, Antalya, Turkey, 26 - 30 April 2015, (Summary Text)

2015

190. Di George Sendromu Tek merkezden takipli hastaların özellikleri

Ayça K., ÖĞÜLÜR İ., Safa B., AYDINER E., Dilek Ç., ÖZEN A. O., et al.

1. Klinik İmmünoloji Kongresi, Turkey, 9 - 12 April 2015, (Summary Text)

2015

191. Primer immün yetmezliklerde otoimmünite çeşitliliği

Hatice Ezgi B., Ayça K., NAİN E., Safa B., AYDINER E., ÖZEN A. O., et al.

1. Klinik İmmünoloji Kongresi, Turkey, 9 - 12 April 2015, (Summary Text)

2015

192. Kombine immün yetmezlik seyri gösteren iki ICF olgusu

NAİN E., Ayça K., AYDINER E., Safa B., ÖZEN A. O., Micheal L., et al.

2. Marmara Pediatri Kongresi, Turkey, 12 - 14 February 2015, (Summary Text)

2015

193. Otoreaktif B lebfositler primer immün yetersizlikteki yaramaz çocuk

Ayça K., ÖĞÜLÜR İ., Safa B., AYDINER E., ÖZEN A. O., YÜCELTEN A. D., et al.

2. Marmara Pediatri Kongresi, Turkey, 12 - 14 February 2015, (Summary Text)

2015

194. Adenozin Deaminaz eksikliği klinik heterojenite

Deniz R., Ayça K., NAİN E., Muzafferova N., AYDINER E., Safa B., et al.

2. Marmara Pediatri Kongresi, Turkey, 12 - 14 February 2015, (Summary Text)

2015

195. Konjenital nötropenide yeni bir açılım JAGN1 geninde mutasyon

Safa B., AYDINER E., ÖZEN A. O., DELİL K., Kıykım A., ÖĞÜLÜR İ., et al.

2. Marmara Pediatri Kongresi, Turkey, 12 - 14 February 2015, (Summary Text)

2014

196. G6PC3 Deficiency: A Primary Immune Deficiency Beyond Just Neutropenia

Kiykim A., Baris S., Ozen A. O., Karakoc-Aydiner E., Cicekkoku D., Sawalle-Belohradsky J., et al.

16th Biennial Meeting of the European-Society-for-Immunodeficiencies, Prague, Czech Republic, 29 October - 01 November 2014, vol.34, (Summary Text)

2014

197. Childhood Onset Common Variable Immunodeficiency: A Single Center Experience

Kiykim A., Karakoc-Aydiner E., Baris S., Ozen A. O., Barlan I. B.

16th Biennial Meeting of the European-Society-for-Immunodeficiencies, Prague, Czech Republic, 29 October - 01 November 2014, vol.34, (Summary Text)

2014

198. CHRONIC MUCOCUTANEOUS CANDIDIASIS, AUTOIMMUNE THYROIDITIS AND CEREBRAL MYCOTIC ANEURISM; STAT1 MUTATION

Kiykim A., Aydiner E., Ozen A. O., Baris S., Guran T., Hsu P. A., et al.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.745, (Summary Text)

2014

199. THE EVALUATION OF OUR PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE

BARIŞ S., ÖZEN A. O., Kiykim A., Yuce E. G., Karakoc-Aydiner E., Barlan I.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.745, (Summary Text)

2014

200. CLINICAL HETEROGENEITY OF IMMUNODYSREGULATION, POLYENDOCRINOPATHY, ENTEROPATHY, X-LINKED: PULMONARY INVOLVEMENT AS A NON-CLASSICAL DISEASE MANIFESTATION

BARIŞ S., Schulze I., ÖZEN A. O., AYDINER E., Altuncu E., Karasu G. T., et al.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.719, (Summary Text)

2014

201. Sistemik steroid kullanımının doğal ve edinsel immün yanıt üzerine etkisi

Aksu H., Barış S., Aydıner E., Özen A. O., Gökce İ., Yıldız N., et al.

1. Marmara Pediatri Kongresi, İstanbul, Turkey, 17 - 19 January 2014, pp.35, (Summary Text)

2014

202. Ipex sendromunda yeni bir bulgu Akciğer tutulumu

Barış S., Ilka S., ÖZEN A. O., Karakoç AYdıner E., Altuncu E., Gülsun K., et al.

1. Marmara Pediatri Kongresi, Turkey, 17 - 19 January 2014

2013

203. House dust mite sensitivity determines a distinct subtype in atopic dermatitis

Baris S., Ozen A. O., Akdeniz T., Aydin O., Karakoc-Aydiner E., Saricoban H. E., et al.

World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, Italy, 22 - 26 June 2013, vol.68, pp.440, (Summary Text)

2012

204. Atopic dermatitis: insight into the mechanism

Baris S., Akdeniz F., Ng H. O., Karakoc-Aydiner E., Ozen A. O., Saricoban-Ercan H., et al.

31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Geneva, Switzerland, 16 - 20 June 2012, vol.67, pp.182, (Summary Text)

2011

205. Primary school teachers' knowledge and attitudes about anaphylaxis

Saricoban E. H., ÖZEN A. O., Cengizlier M.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.217-218, (Summary Text)

2011

206. Investigation of filaggrin 501X gene mutation in Turkish children with atopic dermatitis and the role of serum immunoglobulin levels on atopic dermatitis phenotypes

Saricoban E. H., Ozen A. O., Baris S., Turgay I., Oztezcan S., Cengizlier M.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.550, (Summary Text)

2011

207. Food protein induced colitis of infants and older children: altered expression of TNF-alpha, TGF-beta, TGF-beta receptor-1 in colon mucosa

ÖZEN A. O., Gulcan M., Ozkan F., Saricoban H., Cengizlier R.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.727, (Summary Text)

2010

208. Vezikoüreteral reflülü çocuklarda 24 saatlik yaşam içi kan basıncı izlemi: Mikroalbuminüri düzeyleri ile kan basıncı değişimleri arasında ilişki var mıdır?

Kılınç A., Alpay H., Gökce İ., Bıyıklı N., Benzer M., Özen A. O.

6. Ulusal Çocuk Nefroloji Kongresi, Ankara, Turkey, 7 - 10 October 2010, pp.133, (Summary Text)

2010

209. Outcome of hyypogammaglobulinemia in children: immunoglobulin levels as predictors

Ozen A. O., Baris S., Aydyner E., Ozdemir C., Bahceciler N., Barlan Y.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, vol.65, pp.116, (Summary Text)

2010

210. Attention deficit hyperactivity and oppositional defiant disorder symptoms among allergic children

Ercan H., ÖZEN A. O., HARMANCI K., Razi C., Zahmacioglu O., Cengizlier M.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, vol.65, pp.303, (Summary Text)

2010

211. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis

BARIŞ S., ÖZEN A. O., Karakoc-Aydiner E., Yucelten D., Bahceciler N., Barlan I.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, vol.65, pp.286, (Summary Text)

2010

212. Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: 'similarities and differences'

Keles S., Artac H., Kara R., Gokturk B., ÖZEN A. O., Reisli I.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, vol.65, pp.115, (Summary Text)

2010

213. Impact of serum immunoglobulin levels in childhood asthma

Baris S., Karakoc-Aydiner E., Ozdemir C., Ozen A. O., Bahceciler N., Barlan I.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, vol.65, pp.677-678, (Summary Text)

2010

214. Vezikoüreteral reflülü çocuklarda 24 saatlik yaşam içi kan basıncı izlemi: Mikroalbuminüri düzeyleri ile kan basıncı değişimleri arasında ilişki var mıdır?

Kılınç A., Alpay H., Gökce İ., Bıyıklı N., Benzer M., Özen A. O.

46. Türk Pediatri Kongresi, İzmir, Turkey, 18 - 22 May 2010, pp.203, (Summary Text)

2008

215. Serum sICAM-1 Levels of Bronchial asthma patients treated with immunotherapy

Cengizlier R., ÖZEN A. O., Kyzylgun M., Ornek A., Sarycoban H., Berber M., et al.

27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, Barcelona, Spain, 7 - 11 June 2008, vol.63, pp.391, (Summary Text)

2006

216. Metabolic examination and clinical presentation of pediatric urolithiasis in İstanbul: A single center study

Gökce İ., Alpay H., Özen A. O., Bıyıklı N., Özdemir N.

40th Annual Meeting of the European Society for Paediatric Nephrology-ESPN, Palermo, Italy, 7 - 10 October 2006, pp.1590, (Summary Text)

2005

217. Natural history of Helicobacter pylori in childhood and factors determining the epidemiology of infection

Ozen A. O., Ertem D., Pehlivanoglu E.

18th International Workshop on Gastrointestinal Pathology and Helicobactor, Copenhagen, Denmark, 12 - 14 October 2005, vol.10, pp.484, (Summary Text)

2002

218. Sağlıklı çocuklarda yaş ve cinsiyete göre Üst/Alt segment oranı, Kulaç/Boy uzunluk farkı değerleri

Bereket A., Turan S., Bekiroğlu G. N., Berber M., Özen A. O., Akbenlioğlu C., et al.

VII. Ulusal Pediyatrik Endokrinoloji Kongresi, Trabzon, Turkey, 9 - 11 October 2002, (Full Text)

Activities in Scientific Journals

2021 - Continues

Turkish Archives of Pediatrics

Committee Member

2018 - Continues

Astım Allerji İmmünoloji

Editor

Memberships and Roles in Scientific Organizations

2018 - Continues

Ulusal Allerji Klinik İmmünoloji Derneği- İmmünoloji Çalışma Grubu Başkanlığı

Head of Support Program

Peer Reviews in Scientific Publications

April 2020

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

March 2020

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

December 2019

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

March 2019

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

November 2018

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

September 2018

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

November 2017

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

September 2017

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

July 2017

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

July 2017

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

May 2017

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

January 2017

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

December 2016

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

November 2016

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

September 2016

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

August 2016

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

June 2016

JOURNAL OF CLINICAL IMMUNOLOGY

SCI Journal

Scientific Consultations

2020 - Continues

Project Consultancy

Regeneron Pharmaceuticals Inc

Marmara University, School of Medicine, Internal Medical Sciences, Turkey

Mobility Activity

2019 - 2020

Other

Lecturing

Hoca Ahmet Yesevi Türk Kazak Üniversitesi, Kazakhstan

Awards

January 2025

Tubitak Bilim Ödülü

Tübitak

January 2025

Technology Transfer Impact Award, 2025

Federal Laboratory Consortium

July 2024

EFIS Eastern Star Award

European Federation Of Immumological Societies

October 2022

2022 TÜSEB Hizmet Ödülü

Tüseb

October 2021

Türk - Amerikan konsorsiyumu ile doğuştan bağışıklık kusurlarının genomik incelemesi

Yüksek Öğretim Kurumu (Yök) Kurumsal Ödül- Marmara Üniversitesi- Uluslararası İşbirliği Üstün Başarı Ödülü

September 2021

EFIS Diversity Task Force Publication Award

The European Federation Of Immunological Societies (Efıs)

January 2021

2019 Yayın ödülü

Marmara Üniversitesi

Invited Talks

October 2020

World Immune Regulation Meeting. Dramatic metabolic recovery following precision therapy of CHAPLE syndrome.

Conference

World Immune Regulation Meeting -Switzerland

October 2020

ESID 2020. Broadly Effective Metabolic And Immune Recovery With C5 inhibition in CHAPLE Disease.

Conference

ESID, 19th Biennial Meeting of The European Society for Immunodeficiencies.-Turkey

December 2019

Targeting complement in gut leakiness: A novel approach in protein-losing enteropathies. World Allergy Congress 2019

Conference

World Allergy Organization-France

December 2019

3rd J Project Congress. Treatment of CHAPLE Syndrome Patients with Eculizumab

Conference

3rd J Project Congress-Turkey

October 2019

ESID2019. Dramatic recovery following precision therapy of CHAPLE syndrome with eculizumab

Conference

European Society of immunodeficiencies.-Belgium

October 2019

First Congress of Southeast European Pediatricians with International Participation. CHAPLE syndrome (CD55 deficiency with Hyperactivation of complement, Angiopathic thrombosis, and PLE): From discovery to translation into health

Conference

First Congress of Southeast European Pediatricians with International Participation-Bosnia And Herzegovina

December 2018

Functional Genomics 2018, Big Data to Clinic. Genomics Research Uncovers the Primary Role of Complement Pathway in a Familial Form of Protein Losing Enteropathy

Conference

Functional Genomics 2018, Big Data to Clinic.-Turkey

October 2018

ESID2018. A FLOW CYTOMETRY- BASED SCREENING FOR CD55 DEFICIENCY IS A RAPID AND RELIABLE DIAGNOSTIC TOOL.

Conference

The European Society of immunodeficiencies-Portugal

September 2018

5th European Congress of Immunology. Early onset protein losing enteropathy and thrombosis in inherited CD55 deficiency

Conference

5th European Congress of Immunology.-Netherlands

April 2018

The Işıl Barlan symposium on primary immunodeficiency in Turkey.

Workshop

Marmara Üniversitesi-Turkey

March 2018

World Immune Regulation Meeting XII. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis.

Conference

World Immune Regulation Meeting XII.-Switzerland

Scholarships

2020 - 2020

Travel Award, Oral Presentation, Plenary Session

University

2018 - 2018

Travel Award, Oral Presentation, Plenary Session

Other International Organizations

2015 - 2017

Research Fellowship Award

Other International Organizations

2014 - 2015

2219 Doktora Sonrası Araştırma Bursu

Other International Organizations

Citations

Total Citations (WOS): 2605

h-index (WOS): 27

Scientific Research / Working Group Memberships

2020 - Continues